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Abstract

Older adults with neurocognitive disorders are at high risk for medication non-adherence,
while being vulnerable to great injury from regimen deviations. Informal caregivers often aid in
healthcare management for these individuals. The current study compared the efficacy of two
online health education interventions designed to increase caregiver health related knowledge for
use with care recipients. Women (N=35) assisting a cognitively impaired older person with
medications, were randomly assigned to one of two online health education conditions (1)
narrative vignettes depicting actors encountering common medication challenges, and written
materials or (2) written materials and didactic video clips of information from medical experts.
It was hypothesized that narrative group participants would show greater improvements in
several domains of functioning when compared to didactic group participants. Results showed
equivalent participant satisfaction between groups, and that caregivers did not improve
differentially between condition, over time, in the domains of medication hassles, patientprovider communication, medication management adherence, or self-efficacy. There was no
main effect of time on caregiver reported hassles, patient- provider communication or medication
adherence. There was a significant main effect of time on caregiver self-efficacy for controlling
upsetting thoughts about the caregiving situation F (1, 33) = 8.07, p < .001, p = .20, achieved
power = .79. Secondary analyses revealed that caregivers in the narrative vignette condition
showed significant increases in overall self-efficacy for controlling upsetting thoughts, from pretreatment (M = 62.95, SD = 33.55), to post treatment (M = 72.38, SD = 31.27), t(17) = -2.53, p
=.02, as well as within several specific domains of self-efficacy for controlling upsetting
thoughts. Future directions include replication of these findings, introducing a no-treatment
control, and investigation of effective intervention components through dismantling trials.
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Medication Non-Adherence in Community Dwelling Older Adults with Dementia: An
Educational Intervention for Family Caregivers
The U.S. is experiencing an unprecedented shift in age demographics (U.S. Public Health
Service, 2002). At present, 35 million older adults live in America, a number which will nearly
double by the year 2030 (Centers for Disease Control and Prevention and The Merck Company
Foundation, 2007). By that time older adults will comprise 18.6% of the population compared to
12.4% in 2000 (U.S. Census Bureau, 2004), representing one of the fastest growing groups in the
country. Although the implications of these shifts for healthcare provision and policies have
been discussed at great length, less attention has been allocated to medication specific concerns.
Medication non-adherence, defined as any deviation from a prescribed regimen capable
of impacting intended effects, is a pressing behavioral health issue for older adults living in the
community (Fine et al., 2009). On average, older adults are diagnosed with three to five chronic
health conditions (e.g. diabetes, high blood pressure, arthritis) and manage these conditions with
an average of 5 medications (Center for Disease Control and Prevention and the Merck Company
Foundation, 2007). As a result, they are the largest population of medication consumers in the
U.S. (Center for Disease Control and Prevention and the Merck Company Foundation, 2007).
Although they comprise 13% of the population, they consume 34% of all prescription
medications, and 30% of all over-the-counter medications. In a recent meta-analysis, over 90%
of studies found increasing numbers of prescriptions to be associated with non-adherence (Vik,
Maxwell, & Hogan, 2004). Accordingly, older individuals have more opportunities for nonadherence than other segments of the population (Ferinni & Ferrini, 2000).
Estimates vary slightly, but most projections indicate that over 50% of older adults in the
community do not follow regimens as prescribed by medical personnel. One self-report study
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found that approximately 53% of community dwelling older persons describe themselves as
medication non-adherent. Because estimates based on patient self-report do not factor in the
effects of poor insight and social desirability, a 53% level of non-adherence may represent an
underestimation of true rates (Roth & Ivey, 2005). Recent meta-analytic studies that include
multiple methods of estimation have placed non-adherence at an average rate of 64% in
community dwelling older adults (Banning, 2009), with the highest estimates at 80% nonadherence (Center for Disease Control and Prevention and the Merck Company Foundation,
2007). Despite variance in prevalence rates, however, data suggest that medication nonadherence within older adults is alarmingly high.
The prevalence of non-adherence is especially concerning when understood in the
context of negative health consequences, including adverse drug events (ADE). An ADE is
defined as “any injury caused by/ or directly related to medication ingestion or errors in
medication ingestion” (Institute of Medicine, 2007). These events include allergic reactions,
fever, confusion, falls, renal failure, liver failure or death. Such non-adherence related ADEs are
disquieting in light of age-related physical vulnerabilities (Fried & Walston, 2003). Unlike other
populations, older adults have decreased homeostatic reserve; older bodies have more difficulty
maintaining the physiological balance necessary to fight infections and, more importantly,
overcome acute or chronic insults (Fried et al., 2003). Because homeostatic reserve is reduced
by chronic health conditions, those who are taking the greatest number of medications for these
conditions are the most vulnerable. As a result, even small errors in an older person’s
medication regimen may have catastrophic consequences (Fried et al., 2003).
Decreased homeostatic reserve leads to more destructive bodily consequences in older
adults than in younger adults. Older individuals are more susceptible to a host of injuries from
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medications, including allergic reaction, renal/liver failure, excess disability (from frailty), injury
from falls, death, delirium, depression, confusion, glucose fluctuations and memory impairment
(Bates, 2007; Beery et al., 2010; Inouye, 2006; Murray & Callahan, 2003). Many of these
consequences also have higher chronicity in older adults than younger adults (Bates, 2007; Beery
et al., 2010; Inouye, 2006; Murray & Callahan, 2003).
It is important to note that polypharmacy in older adults combined with medication nonadherence, may increase the risk for ADEs and the severity of the events (Arnold, 2008). Mixing
medications in ways other than prescribed may alter dose response as well as organ functioning
(Arnold, 2008; Schmader et al., 2004). If the individuals taking multiple medications are not
closely monitored, any side effects related non-adherence and polypharmacy will multiply as a
function of the time between medication adjustments (Schmader et al., 2004). Further, the use of
multiple medications, and problems adhering to a prescribed regimen, may increase the
possibility of adverse medication related events (e.g. hospitalization); one study found that
approximately 55% of older adults admitted to an ambulatory care setting had experienced at
least one such instance (Gandhi et al., 2003).
In addition, older persons who are medication non-adherent to prescribed regimens have
poorer global health outcomes than those who are more adherent (DiMatteo, Giordani, Lepper, &
Croghan, 2002). Individuals who take medications as directed experience fewer disabilities, and
enjoy improved chronic health conditions as quantified by changing cholesterol levels, blood
pressure, glucose, and other objective measures (Banning, 2009; DiMatteo et al., 2002). Older
adults who are not taking medications in the manner that they were prescribed can experience
excess disability such as frailty, ambulatory problems, disability related to exacerbated health
conditions, and objective decreases in positive indicators of health (Banning, 2009; Bates, 2007;
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Beery et al., 2010). These non-adherent individuals also have shorter overall life expectancies
(DiMatteo et al., 2002). One study demonstrated that older adults who were prescribed statins, a
cholesterol lowering drug for diabetes mellitus, had a death rate which was doubled by
medication non-adherence. Similarly, older adult patients who were non-adherent on the
medication Clopidogrel, a drug used to prevent blood clotting while utilizing a drug eluting stent
for diabetes, showed a death rate which was nine times greater than those who adhered to the
prescribed regimen (Spertus et al., 2006).
With non-adherence and resulting ADEs, individuals can also incur high financial cost
from increased emergency department admissions, elongated hospital stays, and added physician
visits or medical testing (New England Healthcare Institute, 2009; Patel & Taylor, 2002).
Approximately 30% of all hospital visits and 11.4% of emergency room admissions in older
adults are linked to medication non-adherence (Col, Fanale, & Kronholm, 1990; Schlenk,
Dunbar-Jacob, & Engberg, 2004). Additional costs may affect the families of non-adherent
individuals. For instance, family members may suffer lost wages due to time spent addressing
medical repercussions. On a macroscopic scale, medication non-adherence leads to costs paid by
the federal government through taxpayer funds (Col et al., 1990; Schlenk et al., 2004).
Improved medication management, however, could likely reduce these economic costs.
Medication Non-Adherence in Community Dwelling Older Adults with Progressive
Neurocognitive Disorders
Older adults with Alzheimer’s disease and other neurocognitive disorders are especially
impacted by medication non-adherence. Quality of thinking and self-awareness, as well as
memory and executive deficits can all play a role in medication management concerns.
Dementia, the primary symptom of many neurocognitive disorders, is defined broadly as
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“significant cognitive decline from a previous level of performance in one or more of the
following domains – complex attention, executive function, learning and memory, language,
perceptual-motor or social cognition” (American Psychiatric Association, 2013). Dementing
neurocognitive disorders are further specified with the following subtypes: Alzheimer’s disease,
vascular disease, Lewy body disease, neurocognitive change due to a general medical condition,
cognitive change due to HIV infection, cognitive change due to traumatic brain injury,
Parkinson’s Disease with cognitive change, Huntington’s disease with cognitive change, Pick’s
disease with cognitive change, cognitive change due to prion disease, substance induced
persisting neurocognitive disorder, neurocognitive disorder due to multiple etiologies,
frontotemporal lobar degeneration and unspecified neurocognitive disorder (American
Psychiatric Association, 2013).
The most common subtypes of neurocognitive disorders present with a progressive
disease process. Of the progressive types, Alzheimer’s disease, vascular disease, Lewy body
disease and mixed etiologies of neurocognitive disorder are the most prevalent. Alzheimer’s
disease comprises an estimated 60%-80% of all diagnosed cases and remains the most
predominant neurocognitive disorder subtype (Alzheimer’s Association, 2012). Vascular disease
accounts for an estimated 20-30% of cases while Lewy body disease is presents at a rate of 1020% in older adult populations. Recent studies have shown a high prevalence of mixed
etiologies for neurocognitive concerns, approximately 50%, upon autopsy (Alzheimer’s
Association, 2012). In summary, it is estimated that well over three quarters of all diagnosed
neurocognitive disorders are progressive in nature. Accordingly, the use of the terms
“neurocognitive disorder,” and “dementia,” within this text will refer to the most common
subtype, progressive, and its impact on medication adherence (Alzheimer’s Association, 2012).
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In those with neurocognitive disorders the fundamental symptom of impaired cognition
places these individuals at increased risk for medication non-adherence. A common measure of
cognition, the Mini Mental Status Exam, is the current most frequently utilized evaluation in the
literature base to gauge the level of this cognitive decline. Research indicates that community
dwelling older adults scoring lower on the MMSE have significant difficulty with medication
adherence. One study showed that MMSE scores predicted non-adherence in recently
hospitalized older adults with multiple chronic health conditions (Gray, Mahoney, & Blough,
2001). Scores on the MMSE have also been shown to independently predict adherence to
specific drugs such as anti-hypertensive medications (Salas et al., 2001). Thus, declining
cognition has a well-documented relationship to decreased medication adherence in older adults.
When compared to older adults who do not exhibit cognitive decline, individuals with
neurocognitive concerns demonstrate broadly worse levels of regimen adherence (Douglas,
Letts, & Richardson, 2011). Persons with diagnosed neurocognitive disorders have been shown
to lack basic fundamental knowledge regarding their medication regimens (Sela-Katz,
Rabinowitz, Shugaev, & Shigorina, 2010). In one study, they evidenced significantly poorer
knowledge of medication management than their unimpaired age-matched peers. Approximately
46.8% of those with a dementing illness lacked basic knowledge about their medication regimen
while 6.9% of those without dementia lacked such knowledge (Sela-Katz et al., 2010). This
study also found that basic knowledge regarding one’s medication regimen declined over time as
the neurocognitive disorder progressed. In research examining rates of adverse drug events and
non-adherence in older adults, post-hoc analysis reveal that cognitive limitations are present in
the majority of ADE cases (Field, Mazor, Briesacher, DeBellis, & Gurwitz, 2007). These
unplanned deviations in prescribed regimens cause more accidental deaths than fires and
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wandering in persons with dementia (Douglas at al., 2011). Taken together, this information
highlights the potential for increased medication non-adherence in community dwelling older
adults with neurocognitive disorders.
Medication non-adherence may also have more significant health consequences for those
with neurocognitive disorders. In addition to the reduced homeostatic reserve of older
adulthood, persons with dementing illnesses are more susceptible to episodes of delirium brought
about by non-adherence (Fick et al., 2003; Inouye, 2006). Because dementia is a chronic injury
to brain functioning, small physiological changes have a higher potential to cause injuries above
and beyond what is the case for those who age without a dementing illness. Persons with
neurocognitive diseases do not easily recover from such physiological insults. Individuals who
suffer from delirium superimposed on dementia are at increased risk for accelerated cognitive
decline, multiple re-hospitalizations, and often, death (Fick et al., 2003; Inouye, 2006).
Medication non-adherence in older adults with neurocognitive disorders becomes
especially pressing in the context of the previously discussed demographics. At present, it is
estimated that approximately 5.2 million Americans are affected by some form of dementia,
most of which are progressive. By the year 2050, the number of seniors with irreversible and
incurable dementias will increase to approximately 16 million (Alzheimer’s Association, 2010).
Thus, the problem of medication non-adherence in older adults with neurocognitive concerns
will continue to grow.
Given the likelihood for high prevalence and additional health consequences, medication
adherence in older adults with neurocognitive disorders is a critical behavioral health issue.
Despite the need for data and interventions, however, the research in this field is in its infancy.
What follows is a parallel review of interventions to improve medication adherence in all older
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adults as well as those with dementia. The review of the broader older adult population shows a
larger literature base which serves to highlight our lack of knowledge in those with
neurocognitive concerns. The parallel structure also uses data available for older adults as a
foundation for understanding possible interventions in community dwelling older adults with
dementia. Overall, the current data points to the possible efficacy of interventions targeting
informal caregivers of older adults.
Adherence Interventions in Community Dwelling Older Adults
Current literature shows that successful adherence interventions for older adults can be
divided into two basic categories: those with behavioral components and those that provide
psychoeducation. The more basic of these interventions, behavioral modifications, include pill
package changes, alarms that cue for medication administration, self-monitoring of symptoms/
side effects, self-monitoring of medication administration times, and over-the counter usage.
Packaging changes, or recommendations for this modification, are one of the most
frequently used behavioral interventions. In these interventions patients are asked to utilize
containers, such as pill boxes or blister packs, as opposed to their original pill bottles. The new
containers provide a daily organization system and hold all medications to be taken on a given
day or at a specified time within that day. Although few interventions use package changes as an
exclusive intervention strategy, meta-analyses across medication types show large effect sizes
(Cohen’s d = .67) for interventions that discuss blister packaging or pill box organization (Conn
et al., 2009). Mean effect sizes for interventions that do not include this behavioral component
are relatively small (Cohen’s d = .30; Conn et al., 2009). Despite the benefit of simplicity,
however, these interventions have several draw backs. They cannot account for wrong time
errors nor do they aid in following medication specific administration instructions such as “take
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with food” (Banning, 2009; Conn et al., 2009; Heneghan, Glasziou, & Perera, 2007). In order to
counter difficulties in timing, reminder alarms are often utilized along with packaging changes.
In these cases, meta-analyses show the average effect size of interventions without alarms to be
small (Cohen’s d = .30), whereas interventions that discuss alarms systems with pill packaging
show a large effect size (Cohen’s d = 1.06; Conn et al., 2009). The combination of these
behavioral recommendations appears to be most effective in promoting medication adherence,
and should be utilized in future health oriented intervention strategies.
Another promising behavioral intervention is symptom-monitoring and side-effect
awareness, coupled with developing follow-up questions for medical staff (Conn et al., 2009).
This intervention type requires that clients monitor and record their medication usage and that
they monitor changes in health that may be medication related. The strategy teaches participants
to record instances of medication taking behaviors on calendars or other logs, after each
administration. Similarly, symptom monitoring requires patients to log positive and negative
changes in health status which may relate to medication taking behavior (Conn et al., 2009).
These techniques are typically used in parallel and have been associated with a large effect size
(Cohen’s d = 1.18) compared to the low mean effect size (Cohen’s d = .30) for all interventions
(Banning, 2009). This method, when used correctly, increases patient awareness of their current
medication/health patterns and may subsequently change patterns of behavior by increasing the
number and clarity of questions brought to treating personnel (Conn et al., 2009). These large
effect sizes indicate that future interventions for medication adherence would best serve patients
by providing tools to record medication related data, and teaching patients communication
strategies and useful questions for medical staff.
The second class of successful adherence interventions in older adults without cognitive
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impairment are psychoeducational, and are associated with a moderate effect size (Cohen’s d =
.48; Banning, 2009). This intervention type includes a detailed discussion about medication
purposes, medication management strategies, problem solving surrounding adherence, a
discussion of how to effectively communicate with medical personnel and recognizing when
medication administration errors or adverse consequences have occurred (Conn et al., 2009). It
is likely that when adherence interventions in older adults combine these psychoeducational
components and behavioral modifications surrounding pill packaging changes, symptom
monitoring and alarm systems, they may see increased efficacy (Conn et al., 2009).
Adherence interventions in older adults have been demonstrated as effective across
multiple delivery formats. Personnel providing these interventions have included physicians,
pharmacists, nurse practitioners, nurses, psychologists and social workers (Banning, 2009;
Bouvy et al., 2003; Clifford et al., 2006; Conn et al., 2009). One aspect of these interventions
that may be especially attractive is their flexibility in regards to setting of administration
(Banning, 2009; Conn et al., 2009). They can be delivered on an inpatient or outpatient basis or
during home visits and tele-health communications, all with equivalent efficacy (Banning, 2009).
Delivering these interventions through tele-health mechanisms has been shown to reduce the
high cost required to pay personnel for time of delivery, and is reported to be convenient for
patients receiving care (Banning, 2009; Pew Research Center, 2011).
Two interventions of differing intensity demonstrate the efficacy of behavioral and
psychoeducational interventions in flexible formats. The first study by Clifford and colleagues
(2006) recruited cognitively unimpaired older adults (N=410) who had recently been prescribed
a new medication and who had at least one chronic health condition. These participants were
randomized to a treatment as usual group or the intervention group. The intervention group
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received an initial consultation after obtaining their medications and a single phone call, two
weeks later. When called, the intervention group was asked questions based on a semi-structured
adherence interview. These questions inquired about client adherence patterns and addressed
questions or difficulties they experienced in remaining adherent. Pharmacists were allowed to
deviate from this interview as patients expressed individual concerns, but the most common area
of consultation was behavioral modifications (reminder alarms and packaging changes),
symptom monitoring, psychoeducation about side effects, and what questions to ask the
prescribing professional. Overall, patients in the intervention group reported higher medication
adherence (p = .032) and reported fewer medication related difficulties (p = .021) postintervention. This intervention provided evidence that tele-health behavioral modification and
psychoeducation may be an effective means for improving adherence.
The second psychoeducational intervention was a pharmacist led care plan spanning six
months (Bouvy et al., 2003). This study included 152 older adult heart failure patients
prescribed loop diuretics after a hospital visit. Patients with cognitive impairments were
excluded from the study. When filling their prescriptions, patients in the randomized group
received a semi-structured interview designed to problem solve around medication nonadherence. After this interview, the intervention group received 6 monthly consultation phone
calls designed to answer patient medication questions and provide broadly based behavioral tips
for adherence. The treatment as usual group did not receive interviews or phone calls. All
patient adherence data was measured by a MEMS device assessing adherence to the diuretic
regimen. Patients who received the intervention had significantly fewer days of non-adherence,
140/7656 days (1.8%), when compared to those who did not receive the intervention at 337/6196
(5.4%) days of non-adherence.
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As such, the literature supports the efficacy of behavioral interventions, telecommunicated behavioral modification tips, and psychoeducation to increase medication
adherence. Nevertheless, the current state of interventions for medication adherence in older
adults demonstrates two critical weaknesses. First these techniques have only been utilized in
cognitively unimpaired older persons. Second, the majority of these interventions lack clear
theoretical underpinnings (Conn et al., 2009). As a result, this manuscript further reviews the
relatively sparse data regarding medication adherence interventions in older adults with
neurocognitive disorders. Afterwards, an intervention that includes explicit theoretical
underpinnings and addresses weaknesses in present treatment strategies is described.
Adherence Interventions for Community Dwelling Older Adults with Progressive
Neurocognitive Disorders
There is a dearth of literature for adherence interventions in community dwelling
individuals with dementia. To date, only one study has implemented a medication adherence
intervention for this population (Smith, Lunde, Hathaway, & Vickers, 2007). The study utilized
a telephone reminder strategy to increase adherence and included those with both mild cognitive
impairment (MCI) and dementia (N=14). The individuals received communications from a
trained research assistant in the morning, at noon and before bed. The group receiving the
intervention maintained medication adherence of approximately 80% while those who did not
receive the intervention exhibited expected dementia related decline to adherence of 62%. There
were no significant improvements between baseline medication adherence and post-intervention
adherence rates.
This study represents a pioneering effort in an understudied population, but it
demonstrated several substantial limitations to generalizability. Firstly, the majority of
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individuals in the sample had a diagnosis of mild cognitive impairment. They did not qualify for
a full neurocognitive disorder diagnosis as their cognitive declines did not yet impact daily
functioning. The remainder of the sample included individuals in the beginning stages of
Alzheimer’s disease. This has two implications. These results may not hold for a true
population of individuals with diagnosable neurocognitive disorders and this intervention type
may not be helpful to those in latter stages of the disease process. Another limitation to
generalizability is that the individuals with MCI were not divided into amnestic type or nonamnestic subtypes. This is important as amnestic individuals have a higher likelihood of
conversion to full dementia (Alzheimer’s Association, 2012). Thus, it is unclear what proportion
of the MCI population had an increased potential for impairment. Because the majority of the
sample included individuals with MCI, and because the authors did not assess for type of MCI, it
is likely that study may not generalize to individuals in the community with full progressive
neurocognitive concerns.
One study that supports this assumption of limited generalizability was designed by Insel
and Cole (2005). This study implemented an individually tailored intervention designed to
increase cues for medication memory in older adults and, thus, improve medication adherence
(N=27). For example, if a coffee drinker prepared a pot of coffee in the morning and needed to
take medication at that time, the pill bottles were placed next to the coffee maker. This was
tailored to each individual. The primary outcome for this research was pill counts. This
intervention increased medication regimen adherence in older adults across time from an initial
level of 64.7% adherence to 78%. However, when they removed individuals scoring 1 SD below
age norms on the MMSE (N=6), adherence rates began at 70.6% and were increased to 86%.
Therefore, removing those who qualified for a dementia diagnosis caused improvement rates to
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jump drastically. Taken together, this information implies that interventions focused solely on
the person with dementia may see low efficacy. Considering the progressive nature of many
dementias, this effect may be amplified with time.
The Role of Informal Dementia Caregivers in Medication Adherence
Informal caregivers, family, kin, and chosen family, are the most common source of
assistance for older adults with cognitive limitations (Alzheimer’s Association, 2011; Schulz &
Martire, 2004). Approximately 70-80% of individuals with a dementing illness live in the
community and of those individuals, 75% receive care from a family member or friend
(Alzheimer's Association and National Alliance for Caregiving, 2004; Office for National
Statistics, 2005; Schulz & Martire, 2004; US Census Bureau, 2005). A recent national survey
completed by the Alzheimer’s Association found that 43.5 million adult family/informal
caregivers care for someone 50+ years of age and 14.9 million care for someone who has
Alzheimer's disease or other dementia. (Alzheimer's Association, 2011). Medication
management is a particularly complex task that frequently falls within the domain of caregiving
(American Psychiatric Association, 2010; Arlt, Lindner, Rosier, & Rentelnkrus, 2008; Travis,
Faan, Hsueh-Fen, Kao & Acton, 2005). Of the 14.9 million dementia family caregivers in the
U.S., over half report aiding with medication management at some point in the care process
(Alzheimer’s Association, 2012; American Psychiatric Association, 2010; National Alliance for
Caregiving in Collaboration with AARP, 2009; Travis, Kao, & Acton, 2005).
Although assuming such roles benefits both the patient and families in some ways
(Hilgeman, Allen, DeCoster, & Burgio, 2007), many who become caregivers pay heavy
psychological and physical tolls. (Graesel, 2002; Kam-Mei, & Au, 2011; Schulz, O’Brien,
Bookwalla, & Fleissner, 1995). Overall, studies have found that these dementia family
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caregivers are generally more distressed than caregivers of physically impaired elders (Ory, Yee,
Tennstedt & Schulz, 2000). This distress includes high rates of clinical depression and/or
depressive symptoms (Cassie, & Sanders, 2008; Schulz & Martire, 2004;), high rates of other
negative emotions such as anger, frustration, burden, and fear (Ory et al., 2000), and other
indices of distress, such as family conflict over caregiving, significant emotional strain, financial
hardship, and reduced time for leisure pursuits (Ory et al., 2000; Pinquart & Sorensen, 2003).
Physical tolls are also pervasive; Vitaliano et al. (2002) and Vitaliano, Young and Zhang (2004)
found that caregivers had a greater prevalence of heart disease, high blood pressure and
metabolic syndromes, than non-caregivers of the same age. Still other studies have found
complaints of bodily aches and pains, greater prevalence of diabetes, allergies, and use of nonprescription pain medication to be common in dementia caregivers (Coon, et al., 2004; Pinquart
& Sorenson, 2003). Approximately 17% of caregivers believe their health, in general, has
gotten worse since assuming caregiving responsibilities and 17-35% of caregivers report their
health as fair or poor (Feinberg, Reinhard, & Choula, 2011). Thus, the stress of the caregiving
role, which frequently includes medication management, has the potential to produce negative
mental health consequences in family caregivers.
Interventions targeting informal caregivers: General and medication related.
Numerous interventions have been developed to address the distressing effects of caregiving, but
very few teach specific information for managing the elder’s health and medication. Of the
interventions published in the past decade, there have been multiple reviews support the efficacy
of those designed to reduce stress or improve mood (Brodaty, Green & Koschera, 2003; Schulz,
Martire & Klinger, 2005; Sorensen, Pinquart & Duberstein, 2002). A review by GallagherThompson and Coon (2007) that used strict criteria for identifying psychosocial caregiver
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interventions as evidence based, found that three categories could be so considered at the present
time; psychoeducational skill-building programs (e.g., Coon, Thompson, Steffen, Sorocco &
Gallagher-Thompson, 2003); psychotherapy (e.g., Gallagher-Thompson & Steffen, 1994); and
multi-component interventions (those using several distinct types of treatment such as support
groups plus family meetings and case management; e.g., Mittelman, Roth, Coon & Haley, 2004;
Zarit & Zarit, 2007). Psychoeducational interventions, which derive from behavioral and
cognitive theories and therapies (cf. Beck, Rush, Shaw & Emery, 1979; D’Zurilla, 1986;
Lewinsohn, 1974; Lewinsohn, Munoz, Youngren & Zeiss, 1986) are often preferred by family
members.
Despite the overall findings that psychoeducational and combination interventions are
best suited to assuage caregiver stress, there are some components of the caregiving process that
remain under-researched with a resulting lack of interventions. One such paucity exists in the
realm of caregiver based medication management. Medication management is an especially
critical component of the caregiving role, as it directly impacts care-recipient health. It can also
result in hassles and increased caregiver strain (Thornton & Travis, 2003). Caregivers managing
medications must be aware of scheduling logistics, timing of administration, safety issues, sideeffects, knowing what to do in an emergency, issues of polypharmacy and information seeking
when appropriate (Travis et al., 2005). If any of these processes are not well managed, it could
result in negative physical consequences for the care-recipient as well as financial and emotional
consequences for the caregiver (Bates, 2007; Beery et al., 2010; Inouye, 2006; Murray &
Callahan, 2003).
Nevertheless, present literature searches reveal only one treatment study that sought to
include informal caregivers as an intervention point for medication adherence in
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neurocognitively impaired older adults (Kamimura, Ishiwata & Inoue, 2012). Participants were
providing care to an older adult (> 65 years of age) who had a Clinical Dementia Rating Scale
score ranging from 0.5 – 1 (N = 18). The analogue CDR is scored on a five-point scale that is
meant to describe individuals without neurocognitive concerns (0) and with questionable (0.5),
mild (1), moderate (2), and severe (3) neurocognitive difficulties. Caregivers were trained to
program and fill an electronic pill planner, which included alarms and real-time pill dispensing,
throughout the day. They were subsequently instructed to give minimal prompting to the older
adult about managing their medications. The older adult’s medication adherence was calculated
for one week previous to this intervention and after three months of using the electronic pill
planner, using ratio of total prescribed doses and total number of medication doses taken by the
care-recipient (verified by pill count). Results showed that after 3 months of using this device,
approximately 66% of the care-recipients in this study were taking all of their medication doses
in a given day (Kamimura, Ishiwata & Inoue, 2012).
Although this study demonstrates the potential benefits of including caregivers in
healthcare interventions, the findings lack generalizability to certain populations. Namely, this
intervention only included older adults with questionable or mild cognitive impairment, and it is
likely that individuals with greater cognitive impairment would demonstrate more difficulty in
responding to electronic pill planners with reminders. Caregivers were also required to undergo
substantial training by nursing staff in order to operate this device; education took place over
three home visits. This preparation necessitates a sizeable time commitment for staff and
caregivers. Not only is this approach costly, in terms of staff resources, but this may have
limited external validity in a highly time-pressured caregiver population.
Despite the lack of adherence specific interventions, however, current review papers
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suggest that all treatments designed to impact a care dyad, should include psychoeducation about
effective communication strategies and education about cognitive impairment in those with
neurocognitive disorders. These reviews show that interventions targeting specified dyadic
problems produce decreased caregiver stress, higher satisfaction and greater intervention
tolerability, when they teach effective interpersonal strategies (Moon & Adams, 2012).
Additional information, such as clear material describing the causes of confusion in the older
adult, has the potential to increase ease of medication management and subsequent adherence
(Alzheimer’s Association, 2012; National alliance on Family Caregiving, 2009). It opens the
door for continued dialogue between health professionals and caregivers/care-recipients, and
may spur caregivers to seek outside support systems to aid in medication management,
subsequently improving adherence (Alzheimer’s Association, 2012; National alliance on Family
Caregiving, 2009).
Overall, current research suggests that family caregivers may be the most useful primary
point of contact when developing medication related interventions for those with dementia.
Cognitive decline as a consistent predictors of medication non-adherence, (Gray et al., 2001;
Sela-Katz et al., 2010) coupled with the hassles that caregivers experience when managing
medication (Thornton & Travis, 2003), further underscore this group as the most impactful point
of treatment. In addition, interventions that focus on the caregiver have potential to alleviate
both caregiver strain, and may also positively impact the health of the care-recipient. Despite the
need to support cognitively impaired older adults in managing medications, however, there are
few interventions designed to help dyads achieve this goal, fewer that do so using caregivers as a
point of intervention, and almost none that do so by developing an intervention with clear
theoretical underpinnings.
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Understanding Caregiver Medication Management from a Health Model Framework:
Bandura’s Theory of Self-Efficacy
Bandura’s social cognitive theory attempts to explain the way in which individuals learn,
and engage in new behaviors. This theory posits that people acquire a given behavior as a result
of interactions between internal and external factors. Internal influences include cognitions,
transient emotional states, past experiences, expectancies and goals. External influences refer to
the context or the social and physical environment an individual inhabits while learning.
Reciprocal determinism, or the interaction between the person, environment and behaviors,
influences the manner in which an individual learns a given behavior (Bandura, 2001).
Social cognitive theory emphasizes the role of self-efficacy as one of the strongest
internal states acting upon the acquisition of a new behavior. Bandura defines self-efficacy as
the level of confidence one possesses that he/she can perform a given act (Bandura, 1977;
Bandura, 1982; Bandura, 1997). It is a behaviorally specific construct that directly impacts one’s
ability to persist in tasks, despite obstacles. Self-efficacy also varies across domains; an
individual can have high self-efficacy in one area and low self-efficacy in another. Finally, selfefficacy is influenced by environmental context (Bandura, 1977; Bandura, 1982; Bandura, 1994;
Bandura, 1997).
Self-efficacy beliefs originate from several types of experiences. Firstly, they develop
after performance accomplishments. Performance accomplishments occur when an individual
successfully executes a behavior. The individual then believes that they can successfully
perform future domain related behaviors (Bandura, 1982). Efficacy beliefs can also develop
through vicarious experiences. In these cases, an individual observes someone else successfully
completing a given activity. Vicarious experiences are most powerful when the model is a
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similar other (Bandura, 1977; Bandura, 1982; Bandura, 1994). Verbal persuasion and
physiological state changes are the final mechanisms for developing efficacy (Bandura, 1977;
Bandura, 1982; Bandura, 1997). The most effective method for increasing self-efficacy is to
engage in performance accomplishments (Bandura, 1997). Vicarious learning follows in power,
whereas verbal persuasion and physiological state changes have the smallest impact on selfefficacy (Bandura, 1977; Bandura, 1982; Bandura, 1997).
Despite the largely domain specific nature of self-efficacy, however, there are five
scenarios in which efficacy beliefs may generalize. The first scenario is when two tasks require
similar sub-skills. Efficacy beliefs may also generalize when two skills were developed
simultaneously or when cognitive meta-strategies learned for one skill apply to another. In
addition, efficacy beliefs generalize to new experiences when the individual creates similar
cognitive structures for learning a given behavior. Finally, one may experience a
transformational restructuring of beliefs. For example, someone who undergoes a powerful
mastery experience may gain the sense that they can overcome a broad array of challenges
(Bandura, 1977; Bandura, 1982; Bandura, 1997).
Self-Efficacy Theory applied to medication management. Self-efficacy beliefs impact
medication management and health related outcomes across multiple populations. In adults age
18-64, self-efficacy for medication management relates to increased ability to perform
medication management behaviors. A study by Brus and colleagues (2000) examined the
relationship between self-efficacy for adherence to sulphasalazine (a drug for rheumatoid
arthritis) and a pill count measure of adherence. Logistic regressions classifying adults as
adherent or non-adherent, with a cutoff of 80% adherence, showed self-efficacy was a significant
predictor of adherence behavior. A similar study by Gifford and colleagues (2000) demonstrated
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that levels of self-efficacy for managing two multidrug antiretroviral HIV regimens accurately
classified individuals as having excellent adherence (100%), fair adherence (80-99%) and poor
adherence (< 80%). It also showed that adherence and self-efficacy related to lower plasma
concentrations of the HIV virus. In addition, self-efficacy is linked to adherence with other
behavioral regimens recommended by physicians. In a recent study, (N=463) individuals with
diabetes were shown to be more adherent to physician recommended diet and exercise when they
reported high self-efficacy for following health related regimens, and higher self-efficacy for
managing distressing emotions around these health based changes (King et al., 2010).
The relationship between self-efficacy and medication adherence extends across age
groups. In a population of older adults who experienced a transient ischemic attack (TIA) or
stroke, those who reported higher self-efficacy for controlling thoughts about medication
management showed greater levels of medication adherence. Level of self-efficacy and
adherence related to a higher likelihood of meeting target glucose/cardiac outcomes (Ireland,
Arthur, Gunn, Oczkowski, 2010). Similarly, older adults with high self-efficacy demonstrate
greater ability to manage osteoporosis medications and exhibit improved medical outcomes
(Resnick, Wehren, & Orwig, 2003). Additional data demonstrate that self-reported medication
adherence is significantly associated with self-efficacy for remembering to administer
medication (Mcdonald-Miszczak, Maris, Fitzgibbon, & Ritchie, 2004).
Finally, numerous studies show that self-efficacy relates to medication management,
across cultures. Lewis (2011) demonstrated that low income African Americans with high selfefficacy for positive medication related behaviors and high self-efficacy for managing emotions
surrounding health conditions, exhibited greater adherence and better overall communication
with medical providers. HIV positive patients recruited from a hospital in Hong Kong, who
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reported higher self-efficacy for their medication regimen, also demonstrated higher selfreported medication adherence (Mo, & Mak, 2009). Israeli patients managing oral and injected
medications for diabetes exhibited the same pattern: higher self-efficacy related to increased
ability to manage medications (Mishali, Omer, & Heymann, 2010). Lastly, medication
adherence efficacy in Taiwanese organ transplant patients predicted higher levels of medication
adherence post-transplant (Weng, Dai, Huang, & Chiang, 2009).
Social Cognitive Theory and a caregiver based intervention. At present, no other
model exists which reliably predicts improved medication management across age groups and
ethnicities (Bandura, 2004; Conn et al., 2009; Jackson, 2011). Further, self-efficacy based
interventions are easily tailored to individual concerns. Bandura (2004), notes that each
individual has a unique level of pre-existing efficacy as well as a unique set of obstacles and a
differing course of progress. He also explains that this model allows for interventions
administered in a variety of modalities (Bandura, 1998; Bandura, 2004). As a result,
interventions based in self-efficacy theory allow for flexibility in content and administration.
These facets may be highly beneficial to informal dementia caregivers.
The Current Study: Specific Aims and Hypotheses
The primary aims of this study were to examine the efficacy of a web based intervention
that utilized Bandura’s theory of self-efficacy and targeted dementia family caregivers. In this
study, a multimedia health education condition based on enacted true-to-life vignettes was
predicted to increase caregivers’ medication management self-efficacy through observational
learning of similar others. The same information and suggestions delivered in traditional voice
and written text of experts formed the didactic comparison condition. Expert testimony has been
demonstrated to be far less effective in shaping self-efficacy beliefs and effective behaviors
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(Bandura, 1997), while interactive vignettes maximize participants’ engagement with the online
educational materials (Epstein, Collins, Thomson, & Pancella, 2007; Epstein & McGaha, 1999;
Epstein, Thomson, Collins, & Pancella, 2009). Because women are disproportionately likely to
provide medication assistance to aging family members, this intervention focused on female
caregivers (U.S. Bureau of the Census, 2005).
This intervention utilized an internet based modality that encompassed the
psychoeducational and behavioral content areas previously highlighted as effective in the older
adult, cognitively impaired older adult, and caregiver literature. This internet modality was
selected because tele-health interventions demonstrate high efficacy for improving medication
related behaviors and may be particularly well suited to the busy schedules of informal
caregivers (Steffen & Mangum, 2003). In addition, internet-based services create access for
underserved rural caregivers (Steffen & Mangum, 2003). Finally, the internet has become an
important source of health information, with eighty percent of internet users, and fifty-nine
percent of the US population, searching online for health material (Pew Research Center, 2011).
The proportion of adults aged 65 and older who use the internet to search for information has
grown to 53%; of these, 70% report going online daily (Pew Research Center, 2011). Thus, the
internet is a viable and convenient medium for providing flexible and accessible health
education; such flexibility is linked to the success of recruitment and retention in health
education and intervention research (Coday et al., 2005).
Specifically, the goals of this online health education intervention were to increase
positive behaviors associated with effective medication management strategies by women caring
for a cognitively impaired older relative/friend and to decrease medication-related caregiving
hassles. The hypotheses that were examined are as follows:
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Compared to participants in the traditional online health education condition, dementia
caregivers assigned to the narrative vignette condition would:
1). Report higher levels of satisfaction with the intervention at the post-intervention
assessment (1 month).
2). Show a greater pre to post-intervention decrease in medication refill and
administration hassles.
3). Show a greater pre to post-intervention increase in self-reported positive
communication behaviors with medical providers.
4). Show a greater pre to post-intervention decrease in medication non-adherent
behaviors for care-recipient medication regimens.
5) Show greater pre to post-intervention increases in self-efficacy for controlling
upsetting thoughts related to the caregiving situations.
Methods
Participants
Eligible participants were (a) women aged 18 years and older, who (b) assisted a
community-dwelling biological or “chosen” earlier-generation relative by (c)
accompanying/providing transportation to a medical appointment of this relative at least once in
the past year and who (d) were engaging in at least one of the following caregiving activities
related to prescription drugs: Ordering, retrieving, organizing or administering medication,
routinely reminding the older adult to take medications, or sharing in decision-making with care
recipient and physician to begin, hold, increase, decrease, or discontinue a medication and who
(e) endorsed a score of 2, “somewhat distressed,” or more, on two items of the Family Caregiver
Medication Administration Hassles Scale (Travis et al., 2003). Similar criteria have been used
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successfully in research on medication administration by family members of older adults (Travis
et al., 2003). This definition of caregivers is culturally sensitive to women who provide
significant care for non-relatives from a previous generation (e.g., caring for “fictive kin,”
neighbors, and church members in African American communities, as well as for older gay men
and lesbians who may not have access to support from biological family members).
Care-recipients were required to have a caregiver reported diagnosis of dementia.
Additional inclusion criteria for the care recipient were no lifetime reported history of (b)
schizophrenia, (c) bipolar disorder, (d) suicide attempts, (e) Huntington’s Disease, (f)
Korsakoff’s Disease, (g) Multiple Sclerosis, (h) HIV, (i) traumatic brain injury or (j) drug/
alcohol dependence.
Recruitment. All assessment and intervention tasks were conducted online (with
available telephone technology support), which allowed for local and nationwide recruitment,
using a variety of strategies. The project advertised on the electronic newsletters and websites for
local and national agencies serving older adults (e.g., Family Caregiver Support Programs of
Area Agencies of Aging) and family caregivers (e.g., National Family Caregiver Association,
Alzheimer’s Association TrialMatch research registry, online family caregiver chat rooms and
groups). This study also utilized the lab’s Constant Contact (online newsletter service) database
generated during a prior Express Scripts measurement development study, for individuals who
indicated interest in receiving information about other research. In addition, the lab created an
active Facebook page and twitter account which advertised the link for the screening survey.
Only “followers” or “friends” on these social media sites were able to see these messages to
minimize non-caregiver responses to the screening survey. Followers of these social media sites
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exclusively included nationwide agencies for aging individuals (e.g. Alzheimer’s Association
chapters across multiple states).
In addition to these electronic methods for recruitment, lab members advertised this study
in-person during the St. Louis, St. Charles, Edwardsville and Rolla Walk to End Alzheimer’s
events. This study also provided recruitment materials at all Alzheimer’s Association Care and
Conquer talks. In addition, presentations were made about the study to Alzheimer’s Association
Faith Ambassadors in the St. Louis area as well as to staff at the St. Louis College of Pharmacy.
Alzheimer’s Association Respite Care Families were also mailed recruitment flyers.
Study Participants
Flow of participants through the study. A total of 467 individuals were screened
before entry into this study and of those 467 individuals, 54 (11.56%), were eligible for the
intervention. One individual was removed before randomization due to a non-working email and
only initials given for the name. Thus, 53 individuals, 11.35%, were randomized to the
experimental narrative vignette treatment condition, or the comparison didactic condition. Of the
53 caregivers randomized, 25 were assigned to the comparison didactic condition (47.17%) and
28 (52.83%) were assigned to the experimental condition (Table 1).
As shown in Table 1, caregivers who were enrolled in the intervention, at pre-treatment,
ranged in age from 26 to 56 (M = 53.43, SD = 9.88). These individuals identified as primarily
White (75.5%), followed by African American (15.1%), Multiracial (7.5%), and Latina (1.9%).
The large majority of these caregivers stated that they were caring for a parent (88.6%). Marital
status was approximately evenly divided, with 56.6% stating that they were married or living as
married. This sample of caregivers was well educated, with the average years of education
equivalent to a bachelor’s degree (M = 16.01, SD = 2.44). About 34% of this sample earned
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between $10,000 - $50,000 a year, while the remaining 66% earned over $50,000 each year.
Individuals entering the intervention reported caring for their loved one for an average of 3.52
years (SD = 2.40). These caregivers reported that, at the time of the survey, they provided about
72% of all of their loved one’s total care.
As shown in Table 2, participants entering the intervention were providing care to
individuals who demonstrated moderate levels of impairment on the IADL, ADL and CDR
(IADL: M = 1.06, SD = 1.42; ADL: M = 3.02, SD = 2.46; CDR: M = 1.45, SD =.80). The most
common neurocognitive diagnosis was Alzheimer’s disease (47.2%), however many individuals
did not know the exact diagnosis of the older adults cognitive difficulties (37.7%).
Approximately 9.4% of participants reported caring for someone with vascular dementia. These
caregivers endorsed managing an average of about 7 prescription medications and 4 over the
counter medications (Rx Meds: M = 7.37; SD = 3.66; OTC Meds: M = 3.51, SD = 1.89). The
most common medical conditions in the care-recipient group, aside from dementia, were high
blood pressure (69.8%) and arthritis (45.3%).
No demographic differences in caregiver age, years of education, level of involvement,
numbers of medicines managed, the relative risk of medicines managed, or current mental health
status, emerged when comparing narrative vignette participants to didactic group participants, at
the initial assessment time point (Tables 1 and 2). Similarly, care-recipients were equivalent on
all demographic variables, including types of medical diagnoses, level of impairment and living
arrangements, as reported by the caregiver. Although no demographic differences between
groups reached significance, some non-significant trends emerged. Overall, the narrative
experimental group showed a lower ratio of enrolled African American participants, at 7.1%,
compared to 24% in the comparison control group (p = .10). In addition, caregivers in the
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experimental group reported that they were caring for individuals with slightly higher levels of
functionality in IADLs, (p = .17; Control M = .80, SD = 1.15; Experimental M = 1.29, SD =
1.61). Nevertheless, these groups were equivalent on all examined demographic variables.
In order to further assess the equivalency of these two groups on primary outcome
variables, independent t-test were run to compare the narrative vignette and comparison didactic
conditions on initial levels of hassles, self-efficacy, medication adherence behaviors and patientprovider communication (Table 3). Several significant differences emerged in the data.
Caregivers in the comparison didactic group reported that they were experiencing overall higher
number of hassles than those assigned to the narrative vignette condition (didactic M = 37.40, SD
= 26.21; narrative vignette M = 27.57, SD = 17.76; p = .01; Cohen’s d = .51). When examined
based on subscales, independent t-tests found that two areas of hassle were driving this overall
difference. Caregivers in the didactic comparison condition reported that they were significantly
more hassled in the areas of Safety (didactic M = 7.36, SD = 6.42; narrative vignette M = 4.68,
SD = 3.94; p = .01; Cohen’s d = .44) and polypharmacy (didactic M = 6.04, SD = 4.30; narrative
vignette M = 3.43, SD = 2.91; p = .03; Cohen’s d = .72) but not in the domains of information
seeking or scheduling logistics. Caregivers did not show any significant differences between the
narrative vignette condition and comparison didactic on initial levels of Self-Efficacy for
Controlling Upsetting Thoughts, medication adherence as measured by the Moriskey Medication
Adherence Scale, or caregiver communication with medical providers.
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Table 1.
Pre-intervention Caregiver Demographic Characteristics; Total and Comparison of Conditions.

Intervention Group

Variable

Intervention Group
Comparison

Total
(N = 53)

Didactic
(n = 25)

Narrative
(n = 28)

F or
χ2

P Value

Age
(M, SD)

53.43
(9.88)

53.92
(9.05)

53
(10.7)

.92

.34

Years of Education
(M, SD)

16.01
(2.44)

15.84
(2.09)

16.17
(2.75)

.91

.35

4.89 (4.24)
2.89 (3.19)
7.24 (4.64)

4.68 (3.72)
2.80 (3.41)
7.60 (4.62)

5.00 (4.73)
2.90 (3.03)
6.93 (4.73)

.90
.04
.30

.35
.84
.59

3.52 (2.40)

3.94 (2.06)

3.32 (2.58)

.91

.35

72.28
(29.02)

77.56
(26.53)

69.17
(29.12)

.47

.50

6.35

.10

.93

.37

3.27

.52

.31

.58

DASS 21 score (M, SD)
Depression
Anxiety
Stress
Total Time as Caregiver in years
(M, SD)
What Percent of Total Care Provided
(M, SD)
Ethnicity n, %
Caucasian
African American
Latina
Multiracial

40 (75.5%)
8 (15.1%)
1 (1.9%)
4 (7.5%)

15 (60%)
6 (24%)
1 (4%)
3 (12%)

25 (89.3%)
2 (7.1%)
0
1 (3.6%)

Married/ Living as married n, (%)

30 (56.6%)

13 (52%)

17 (60.7%)

Relationship to Care Recipient n (%)
Daughter
Granddaughter
Aunt/ Uncle
Close Friend

47 (88.6%)
3 (5.7%)
1 (1.9%)
2 (3.8%)

23 (92%)
2 (8%)
0
0

24 (85.7%)
1 (3.6%)
1 (3.6%)
2 (7.1%)

How Caregiver Helps with
Healthcare, n (%)
Order Medications

48 (90.6%)

24 (96%)

24 (85.7%)

Medication Non-Adherence and Dementia
Pick Up Medications
Drive to Medical Appointment
Help Organize Meds
Help Decide When to Change
Dose
Help Decide When to Start Med
Actually Give the Medications
Participate in Medical
Appointments
Income, n (%)
Less than $5000
$5,000 - $9,999
$10,000 $14,999
$15,000 - $19,999
$20,000 - $20,999
$30,000 - $39,999
$40,000 - $49,000
$50,000 - $59,000
$60,000 - $69,999
Over $70,000
Employment Status, n (%)
Retired
Working Full Time
Working Part Time
Unemployed
* = p < .05.
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49 (92.4%)
52 (98.1%)
51 (96.2%)
44 (83%)

24 (96%)
25 (100%)
25 (100%)
22 (88%)

25 (89.3%)
27 (96.4%)
26 (92.9%)
22 (78.6%)

.85
.91
1.87
.83

.37
.34
.17
.37

46 (86.8%)
44 (83%)

23 (92%)
22 (88%)

23 (82.1%)
22 (78.6%)

1.11
.83

.29
.37

52 (98.1%)

25 (100%)

27 (96.4%)

.91

.31

9.02

.53

0
0
3 (5.6%)
3 (5.6%)
4 (7.5%)
8 (15.1%)
5 (9.5%)
5 (9.5%)
5 (9.5%)
20 (37.7%)

0
0
1 (4%)
1 (4%)
2 (8%)
5 (20%)
1 (4%)
3 (12%)
3 (12%)
9 (36%)

0
0
2 (7.1%)
2 (7.1%)
2 (7.1%)
3 (10.7%)
4 (17.9%)
2 (7.1%)
2 (7.1%)
11 (39.4%)
1.27

.74

10 (18.9%)
25 (47.2%)
6 (11.3%)
12 (22.6%)

4 (16%)
12 (48%)
2 (8%)
7 (28%)

6 (21.4%)
13 (46.4%)
4 (14.3%)
5 (17.9%)
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Table 2
Pre-intervention Care-Recipient Demographic Characteristics; Total and Comparison of
Conditions.

Intervention Group

Variable

Intervention Group
Comparison

Total
(N = 53)

Didactic
(n = 25)

Narrative
(n = 28)

F or χ2

P Value

Age (M, SD)

83.02 (8.05)

83.00 (6.83)

83.03 (9.12)

1.71

.20

Years of Education (M,
SD)

12.39 (2.53)

12.08 (2.66)

12.68 (2.41)

.01

.94

Care Recipient IADL
score (M, SD)

1.06 (1.42)

.80 (1.15)

1.29 (1.61)

1.98

.17

Care Recipient ADL score
(M, SD)

3.02 (2.46)

2.96 (2.58)

3.07 (2.40)

.64

.43

Care Recipient CDR
Score (M, SD)

1.45 (.80)

1.44 (.79)

1.46 (.81)

.
03

.86

HBLQ Score (M, SD)

3.87 (1.36)

4.08 (1.32)

3.69 (1.39)

.60

.44

Total Number of Rx
Medications (M, SD)

7.37 (3.66)

7.76 (3.91)

7.03 (3.47)

1.20

.28

Total Number of OTC
Medications (M, SD)

3.51 (1.89)

3.32 (1.84)

3.68 (1.94)

.18

.67

Gender, n (%)
Male
Female

.05

.82

12 (22.6%)
41 (77.4%)

6 (24%)
19 (76%)

6 (21.4%)
22 (78.6)

Medical Problem, n (%)
Arthritis
Spinal/ Back Problems
Diabetes
High Blood Pressure
Other Cardiovascular

24 (45.3%)
7 (13.2%)
13 (24.5%)
37 (69.8%)
17 (32.1%)

13 (52%)
2 (8%)
7 (28%)
18 (72%)
8 (32%)

11 (39.3%)
5 (17.9%)
6 (21.4%)
19 (67.9%)
9 (32.1%)

.86
1.12
.31
.11
.00

.35
.29
.58
.74
.99
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Cancer
Pulmonary
Vision
Heavy Alcohol Use
Depression
Anxiety

1 (1.9%)
7 (13.2%)
17 (32.1%)
3 (5.7%)
21 (39.6%)
16 (30.2%)

1 (4%)
4 (16%)
8 (32%)
1 (4%)
10 (40%)
6 (24%)

0
3 (10.7%)
9 (32.1%)
2 (7.1%)
11 (39.3%)
10 (35.7%)

Living Arrangement, n
(%)
With Caregiver
In Own Home, Alone
In own Home, with
other
With Another Relative

24 (45.3%)
13 (24.5%)
13 (24.5%)

13 (52%)
6 (24%)
4 (16%)

11 (39.3%)
7 (25%0
9 (32.1%)

3 (5.7%)

2 (8%)

1 (3.6%)

Care Recipient Dementia
Subtype, n (%)
Don’t Know
Alzheimer’s Disease
Vascular
Lewey Body
Parkinson’s Disease
* = p < .05.

20 (37.7%)
25 (47.2%)
5 (9.4%)
2 (3.8%)
1 (1.9%)

7 (28%)
14 (56%)
3 (12%)
1 (4%)
0

13 (46.4%)
11 (39.3%)
2 (7.1%)
1 (3.6%)
1 (3.6%)

1.14
.32
.00
.24
.00
.86
2.31

.29
.70
.99
.62
.96
.35
.51

4.99

.41
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Table 3
Pre-intervention Comparison between Conditions on Primary Outcome Variables

Didactic
(n = 25)

Narrative
(n = 28)

F

P
Value

Cohen’s
d

Hassles: Information Seeking
Subscale (M, SD)

13.04 (9.80)

10.25 (7.53)

1.70

.98

.32

Hassles: Scheduling Logistics
Subscale (M, SD)

11.00 (8.22)

9.21 (7.31)

.56

.48

.23

Hassles: Safety Subscale (M, SD)

7.36 (6.42)

4.68 (3.94)

8.24

.01*

.51

Hassles: Polypharmacy Subscale
(M, SD)

6.04 (4.30)

3.43 (2.91)

4.85

.03*

.72

Hassles: Total (M, SD)

37.40 (26.21)

27.57 (17.76)

6.75

.01*

.44

Self-Efficacy for Controlling
Upsetting Thoughts: Total (M, SD)

61.37 (26.25)

63.23 (33.76)

3.32

.074

.06

Morisky Medication Adherence
(M, SD)

2.80 (1.58)

2.14 (1.60)

.01

.92

.42

Stanford Patient Communication
(M, SD)

3.54 (.95)

2.96 (1.31)

1.74

.19

.51

Variable

* = p < .05.
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Analysis of Participant Dropout. Individuals who did not complete the postintervention assessment (n = 2), those who never logged into the intervention website (n = 11),
and those who did not log in and did not complete the second assessment (n = 5), were
considered treatment non-completers (Table 4). Of the total participants randomized to the
control didactic condition (n=25), 72% (n = 17) were categorized as treatment completers using
the aforementioned criteria. A total of 61% (n = 18) of all participants randomized to the
experimental narrative vignette condition (n = 28), were considered to be treatment completers.
No significant differences in dropout rates emerged between the didactic and narrative vignette
conditions χ2(1, N = 53) = 0.75, p = .38.
Using independent sample t-tests and Chi Square tests of independence, treatment
completers and treatment non-completers, were compared on several demographic variables and
primary outcome measures (Table 5). Several significant differences arose. Participants who
dropped out of treatment were caring for individuals who were less impaired than those who
completed treatment, as shown by caregiver reported CDR scores (p < .001; Completers M =
1.59, SD = .90; Non-Completers M = 1.19, SD = .46), and caregiver reported ADL scores (p =
.05; Completers M = 2.68, SD = 2.58; Non-Completers M = 3.67, SD = 2.14). Participants who
dropped out of treatment were reporting poorer medication management adherence than
caregivers who completed the intervention (p = .02; Completers M = 2.40, SD = 1.38; NonCompleters M = 2.56, SD = 2.03). Those who dropped out of treatment were also reporting
higher overall level of medication related hassles (p = .04; Completers M = 31.54, SD = 24.31;
Non-Completers M = 33.56, SD = 18.99). Specifically, treatment non-completers endorsed more
difficulty on the hassle subscale associated with polypharmacy than treatment completers (p <
.001; Completers M = 4.62, SD = 4.31; Non-Completers M = 4.72, SD = 2.74). There were no
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additional differences between treatment completers and non-completers on other demographic
variables, such as caregiver age, level of education, mental health symptomatology, level of care
provided, total years providing care, ethnicity, income, employment status or complexity of the
medication regimen they managed. There were no other differences between treatment
completers and non-completers on primary outcome variables, including self-efficacy for
controlling upsetting thoughts or patient provider communication. To visually review this
description of participant flow through the study, see Figure 1 below.
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Participants
Screened
(N=467)

Participants
Meeting
Eligibility (N =54)

Randomized to
Treatment
(N=53)

Narrative Health
Education w/
Vignettes (N=28)

Traditional
Health Education
using Didactics
(n=25)

1 Month
Intervention

1 Month
Intervention

Participants who
completed
treatment (n =
18)

Participants who
completed
treatment (n = 17)

Figure 1. Flow of Participants through the Intervention

Medication Non-Adherence and Dementia

43

Table 4
Frequency Table of Participant Dropout by Type of Non-Completer Status

Participants who Entered
Website

Participants who Did not Enter
Website

Participants who Completed
Post-assessment

35

11

Participants who did not
Complete Post-assessment

2

5
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Table 5
Pre-intervention Comparison of Treatment Completers and Treatment Non-Completers

Treatment
Completers
(n = 35)

Treatment NonCompleters
(n = 18)

F or χ2

P Value

Caregiver Age (M, SD)

53.49 (9.53)

53.33 (10.80)

.06

.81

Caregiver Years of Education
(M, SD)

16.14 (2.61)

15.78 (2.13)

.10

.75

4.37 (4.47)
2.49 (3.01)
6.51 (4.33)

5.78 (3.70)
3.56 (3.48)
8.67 (5.02)

.00
.57
.99

.99
.45
.32

Total Time as Caregiver in years
(M, SD)

3.69 (2.29)

3.13 (2.66)

.05

.82

Percent of Total Care Provided by
Caregiver (M, SD)

72.43 (30.04)

72.00 (27.76)

.54

.67

Caregiver Hassles: Information
Seeking Subscale (M, SD)

11.06 (8.88)

12.56 (8.49)

.71

.40

Caregiver Hassles: Scheduling
Logistics Subscale (M, SD)

9.97 (8.07)

10.22 (7.25)

1.80

.19

Caregiver Hassles: Safety Subscale
(M, SD)

5.89 (5.62)

6.06 (5.03)

.83

.37

Caregiver Hassles: Polypharmacy
Subscale (M, SD)

4.62 (4.31)

4.72 (2.74)

10.10

.00**

Caregiver Hassles: Total (M, SD)

31.54 (24.31)

33.56 (18.99)

4.27

.04*

Self-Efficacy for Controlling
Upsetting Thoughts: Total (M, SD)

61.72 (30.78)

63.69 (29.80)

.12

.73

2.40 (1.38)

2.56 (2.03)

5.80

.02*

Variable

Caregiver DASS 21 score (M, SD)
Depression
Anxiety
Stress

Caregiver Morisky Medication
Adherence (M, SD)
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Care-recipient HBLQ Score
(M, SD)

4.11 (1.23)

3.39 (1.50)

2.31

.14

Care-Recipient CDR score
(M, SD)

1.59 (.90)

1.19 (.46)

18.51

.00**

Care-Recipient IADL score
(M, SD)

.94 (1.28)

1.28 (1.67)

1.09

.30

Care- Recipient ADL score
(M, SD)

2.68 (2.58)

3.67 (2.14)

4.04

.05*

1.17

.76

25 (71.43%)
6 (17.14%0
1 (2.85%)
3 (8.58%)

15 (83.33%)
2 (11.11%)
0
1 (5.56%)
4.62

.33

9.71

.46

6.01

.11

Caregiver Ethnicity, n (%)
Caucasian
African American
Latina
Multiracial
Relationship to Care Recipient n %
Daughter
Granddaughter
Aunt/ Uncle
Close Friend

32 (91.43%)
1 (2.86%)
0
2 (5.71%)

15 (83.33%)
2 (11.11%)
1 (5.55%)
0

Caregiver Income, n (%)
Less than $5000
$5,000 - $9,999
$10,000 $14,999
$15,000 - $19,999
$20,000 - $20,999
$30,000 - $39,999
$40,000 - $49,000
$50,000 - $59,000
$60,000 - $69,999
Over $70,000

0
0
1 (2.86%)
1 (2.86%)
4 (11.43%)
5 (14.28%)
4 (11.43%)
4 (11.43%)
4 (11.43%)
12 (34.28%)

0
0
2 (11.11%)
2 (11.11%)
0
3 (16.67%)
2 (11.11%)
1 (5.56%)
0
8 (44.44%)

Caregiver Employment Status, n
(%)
Retired
Working Full Time
Working Part Time
Unemployed
* = p < .05, ** = p < .001

5 (14.29%)
18 (51.43%)
2 (5.71%)
10 (28.57%)

5 (27.78%)
7 (38.89%)
4 (22.22%)
2 (11.11%)
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Procedures
Women who responded to advertised information about the project, or who directly
obtained the screening assessment link through the aforementioned sources, were directed to an
online screener. Before completing the online screening assessment, participants were asked to
provide informed consent for the study. The consent form emphasized participation as voluntary
and explained that participation could be withdrawn at any time without prejudice to the person
or the care recipient. Participants were offered a $25 gift card for each of their 2 completed
online assessments (intake and post-intervention). This project was reviewed by the University
of Missouri-St. Louis IRB, with approval given before initiating data collection.
Those who met study criteria and provide informed consent for the study, and who
agreed to be enrolled in the intervention, were then sent an email containing the link to complete
the pre-intervention assessment, and were entered into a study tracking log to monitor
completion dates for assessments and timeline for further contacts. In order to reduce survey
fatigue, the initial assessment was broken into four smaller surveys so that participants could
complete them across multiple sittings. Participants were given one week to complete these
surveys, after which they were sent a reminder email to finish the pre-intervention assessment.
Average time to complete the pre-assessment was one week, with zero reminders.
After completion of the pre-intervention assessment, participants were randomly assigned
to one of the two treatment conditions, the narrative vignette treatment program or the
comparison didactic condition. Block randomization occurred after the pre-intervention
assessment as the present study was part of a larger experiment that included both dementia and
non-dementia caregivers. Thus, in order to separate these types of caregiver into two groups, and
evenly balance those in the control and experimental conditions, the project coordinator was
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required to view care-recipient dementia status in the pre-assessment. Although random
assignment was not blind to project coordinator, this individual was required to access only one
of the four initial surveys in order to determine the care-recipient’s dementia status. Of note, all
intervention materials and contact points were pre-determined and thus there was not possibility
of differing participant assignment based on project coordinator knowledge of intervention
condition.
To ensure true random assignment, participants were given an ID number in ascending
order as they entered the study. An online random number generator was used to evenly divide
ID numbers into two groups (narrative and didactic) before the study began. A lab member,
unaffiliated with the project, placed the randomly assigned condition type into sealed envelopes
with the ID number on the front. Once an individual was determined to be in the dementia
group, the envelope with the correct participant number in the group was opened, and the
individual was placed in the condition identified inside the envelope.
Once randomized by condition, individuals were sent “Email 1,” which contained
instructions for using the website as well as a login ID and password. On a weekly schedule,
thereafter, participants were given access to new website materials via internal website stepped
programing. Using this same weekly schedule, participants were emailed and notified that their
access level had been increased, and that they could view more materials. After four total weeks
viewing materials, participants were sent the link to the online post-intervention assessment.
Once again, to reduce fatigue, these interventions were broken into four smaller pieces. All
email contacts throughout the study were standardized – they were identical between groups,
with the exception of brief details provided about the intervention in “Email 2” (e.g. describing
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what participants would see when they entered the website). See Appendix A to review of the
email contact and website access timelines.
In order to ensure the quality of online data collected, steps were taken to guarantee that
participants were providing thoughtful responses. The length of time a participant took to fill out
each assessment was measured and compared to median response times of other participants as
well as time taken by pilot participants and project research assistants, to complete the measures.
Those who completed the surveys in significantly less time than other participants would not be
included in data-analysis in order to protect the quality of data. The average time it took
participants to complete the pre-assessment and post-assessment was approximately 60 minutes
and 45 minutes, respectively. The average time it took pilot participants and project research
assistants to complete the pre-assessment and post-assessment, was 40 minutes and 30 minutes,
respectively. No participants took less than 30 minutes to complete the pre or post-intervention
assessment, and thus, no participants were excluded based on this quality management, timebased criteria.
Experimental Conditions
Four health education areas, described in detail below, were developed to address
specific caregiving concerns related to managing medications for an older adult. All four content
areas were included in both treatment conditions. Throughout this study, both groups viewed the
same online interface – a website entry page with four clickable content areas. During the four
weeks of their participation, all participants were sent weekly emails to notify them that their
access level to the website had been increased. Each participant was assigned a week 1, week 2,
week 3 and week 4 pre-programed access level, that was increased by the project coordinator at
the start of that week. So, with each passing week in the intervention study, information was
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added, but never taken away.
Although the two interventions were identical in the type of information and suggestions
provided, they varied significantly in the presentation of the material. In both groups, week 1-4
access levels contained identical didactic handouts across condition, but additional narrative
video vignettes were only included in the experimental narrative vignette treatment. All
participants were free to choose which branches to view and how much time to spend with the
material throughout the intervention period.
Comparison didactic group. Participants entering the comparison didactic condition
website first encountered a still screen shot with four clickable content areas. When participants
entered any content area, they saw another screen containing one column. This column was
titled “resources” and contained PDF didactic handouts with information about that content area,
and a single video of an “expert” (pharmacist, nurse, psychologist or social worker) providing
brief supplementary information. All material available for a given week appeared as white
clickable links; materials that were to become available in following weeks were grey and visible
but not yet clickable as a link. Materials from previous weeks remained available as participants
progressed through the intervention.
Narrative vignette condition. Participants entering the experimental condition’s website
also encountered a still screen shot with four clickable content areas. In the center of the page,
they saw a clickable section titled “introduction.” Upon clicking the introduction link, a video
appeared, introducing the main narrator of the video vignettes. This actor also briefly described
the types of information that one would expect to see in the coming weeks. When participants
entered any content area, they saw another screen containing two columns. As with the
comparison condition, one column was titled “resources” and contained PDF didactic handouts
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with information about that content area, and a single video of an “expert” (pharmacist, nurse,
psychologist or social worker) providing brief supplementary information.
The narrative vignette condition also included a second column, not present in the control
condition, titled “Story.” This column included brief video episodes, each less than four minutes
in length, showing ethnically diverse care dyads encountering various medication related
challenges as the weeks progressed. Caregivers were directed to the PDF handouts to review
methods for solving the concerns faced by dyads in the videos. A new episode and a new set of
handouts were available to the caregivers each week. Basic medication management information
and suggestions were interspersed throughout these video narratives; the vignettes were designed
for “real life” relevance to caregiving experiences. The episodes began by demonstrating
problem solving in “easy” scenarios and progressed in a graduated manner to more difficult
problem solving scenarios, as is suggested by Bandura’s framework for building self-efficacy.
All content in these videos was taken directly from content in the PDF handouts available in both
conditions. The material available for a given week appeared as white clickable links; materials
that were to become available in following weeks were grey and visible but not yet clickable as a
link. Materials from previous weeks remained available as participants progressed through the
intervention. See Appendix B for a summary of resources available in each content area, over
time.
Health Education Content Areas across Conditions
Managing medications. This content area included a discussion of adverse events
linked to medications (e.g., falls, delirium, nursing home placement, negative health outcomes),
and provided information about the most effective ways to manage scheduling of doses and
refills. This module also included psychoeducation about the role a pharmacist can play in
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medication management problem solving, as well as a list of basic and advanced questions that
can be used to help improve medication management and organizational skills. The module
provided further information about the benefits of assessing interaction effects of over-thecounter medications with prescriptions that the care-recipient already takes; pharmacy staff
consultation was highly encouraged.
Talking together. This content area focused on developing communication skills between
the caregiver and care-recipient. Caregivers were given instruction on how to use basic
communication strategies such as eye contact, tone, and “I” language in everyday medication
management interactions. This content area also provided examples of medication-related
conflict between the caregiver and care recipient, and provided suggestions for effective
communication strategies when negotiating these disagreements. In addition, caregivers were
encouraged to use these communication skills to think about the future with their older loved
one, and were given resources on housing, financial planning, driving and healthcare plans as
they may relate to an older loved one’s physical health conditions. This module also addressed
legal and HIPAA requirements for full communication between family members and healthcare
professionals.
Signs of confusion. Given that caregivers of persons with thinking problems may not know
the strengths and weaknesses of their loved one’s thinking abilities, as they pertain to medication
management, this content area provided participants with information about the signs and
symptoms of delirium and dementia, as well as ways to distinguish the two. Caregivers were
given information about the high rates of undiagnosed delirium and dementia in community
dwelling older adults and the benefits of medical evaluation and diagnosis. Further information
was presented about the process for obtaining a diagnosis for a progressively dementing
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neurocognitive illness, including material about brief cognitive screens and neuropsychological
testing, as well as the domains of thinking measured in these evaluations.
Healthcare visits. This content area provided caregivers with information about how to
prepare for healthcare visits that they attend with their loved one. Caregivers were given a list of
example questions they could ask the medical providers about current medications, newly
prescribed medications, over the counter medications, and side-effects. This module also
addresses legal and HIPAA barriers to full communication between family members and
healthcare professionals. The content area explained the need for signed releases on file in the
patient’s chart to allow these conversations and provided an example of a nationally-available
form for durable power of attorney for healthcare (Five Wishes).
Measures
At intake and post intervention (four weeks later), caregivers completed the following
assessments. All measures were present at both time points, with the exception of the
demographic questions, which were only assessed at pre-intervention, and self-reported
satisfaction with the intervention, which was only assessed in the post-intervention assessment.
Primary outcome measures.
User Satisfaction regarding the Use of the Computer Program Questionnaire
(USUCPQ). This User Satisfaction Questionnaire (Ponpaipan et al., 2010) is an 8-item measure
that assess user satisfaction with online health-based interventions. This measure is based on a 7point Likert scale (0 = Very Unsatisfied, 7 = Very Satisfied), with higher scores indicating
greater levels of satisfaction. The original scale was first utilized in a population of middle aged
Taiwanese caregivers, to explore their satisfaction with an online study to promote increased
exercise and healthful eating among their older loved ones. Although this original study reported
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good distribution in the data (N = 26 caregivers), no further psychometrics were reported. This
scale was selected due to its similarity in user population and function in assessing caregiver
satisfaction with an online health based intervention. The measure explored the following
domains of caregiver satisfaction regarding the intervention a) convenience b) entertainment c)
how interesting the content was d) speed of the modules e) usefulness f) practicality g)
tolerability and h) how much information was presented. There are no subscales for this measure,
rather a maximum of 56 points can be obtained, creating a total satisfaction score. This 8-item
scale demonstrated excellent internal consistency in the current study (α =.96). Results revealed
that the USUCPQ was kurtotic and slightly negatively skewed (Table 6). One univariate outlier
was identified on this measure, within the experimental treatment condition (z > 3.29). This
individual was not removed from analyses due to the small sample size. Instead, mean value
substitution was utilized to replace the individual’s satisfaction score. No transformation was
completed to allow for greater interpretability of the main analyses.
The Family Caregiver Medication Administration Hassles Scale. This measure consists
of 24 items that reflect concerns over keeping prescription medications filled, scheduling
logistics, safety issues, and information seeking (Travis et al., 2003). Higher scores on this
measure indicate greater levels of perceived hassle. It is a self-reported instrument with four
subscales. The first subscale, Information Seeking/ Information Sharing, is comprised of 9 items
that describe education and communication based hassles. The second subscale, Scheduling and
Logistics, contains 7 items and asks about medication management and administration hassles.
The 5-item Safety Issues subscale asks about medication errors and adverse drug effects, while
the 3-item Polypharmacy subscale measures hassles related to interactions with multiple
prescribing providers and managing tasks related to multiple medications. Caregivers are
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instructed to rate each of the items on a scale from 0 = “not a hassle” to 5 = “one of the worst of
all hassles.” Scoring is completed by creating a total summed score of all items and total
summed scores for the subscales. The overall reliability of this instrument in initial
psychometric studies α = 0.95, with subscale reliabilities of the following: Information
Seeking/Information Sharing (α = .92), Safety Issues (α = .83), Scheduling Logistics (α =.90),
and Polypharmacy (α =.80). Test retest reliability was .84.

The overall reliability of this

instrument was excellent in the current study (α = .97), similar to the scale’s original findings.
The hassle subscales had the following internal reliability scores: Information
Seeking/Information Sharing (α = .92), Safety Issues (α = .89), Scheduling Logistics (α =.86),
and Polypharmacy (α =.83). As seen in Table 6, the safety issues subscale was slightly
positively skewed. All other subscales and totals were within normal limits for measures of
normality. As such, no transformations were completed. There was no evidence of outliers on
this measure.
Morisky Medication Adherence Scale. This is an 8-item self-report measure that
describes the medication adherence patterns in a given individual. These items require “yes” or
“no” self-reported responses, where a “yes” response is scored as a one, indicating a nonadherent behavior, and a no is scored as a zero, indicating good medication adherence. Higher
scores on this measure, indicate poorer medication adherence. Individuals with summed scores
of 0 fall in the “high adherence” range, those with a 1-2 fall in the “medium adherence” range
and those who score greater than 2 fall in the “low adherence” range. This measure has been
developed and evaluated for use with low-literacy patients, and has been reported as
demonstrating high criterion validity with medication monitoring devices (Morisky et al., 2008).
In the original literature, this measure demonstrates good internal reliability (α =.83). In the
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current study, this measure was modified such that the caregiver managing medications answer
the questions about the care recipient’s level of adherence. Present results show this measure
was within the low range of acceptability for internal reliability (α =.60). This measure
demonstrated adequate response normality, with little kurtosis and skew (Table 6). No outliers
were identified and no transformations of the data were completed for responses on this
instrument.
Stanford Patient Communication with Physicians. This measure consists of 3 selfreported items that describe patient behaviors while speaking with a medical provider (Lorig et
al., 1996). The instrument instructs patients to rate each of their behaviors on a 5-point Likert
scale from 0 = never to 5 = always. A total score for this measure is obtained by computing the
average of these three items. Higher scores indicate better patient-provider communication. The
overall internal reliability of this instrument is 0.73, with test retest reliability at .89.

This

instrument demonstrated good internal consistency in the current study (α = .70). As seen in
Table 6, the measure was within normal limits for kurtosis and skew. As such, no
transformations were completed. Similarly, there was no evidence of outliers on this measure,
and no data points were removed.
Revised Scale for Caregiving Self-Efficacy: Self Efficacy for Controlling Upsetting
Thoughts. The Revised Scale for Caregiving Self-Efficacy is a 5-item instrument that asks
caregivers to report their overall confidence from 0% to 100% in successfully controlling
upsetting thoughts related to their caregiving situations (Steffen et al., 2002). A 0% confidence
indicates that they believed they could not do the specified task under any circumstances, 50%
confidence indicates that if they gave it their best effort, chances are about 50-50 that they could
perform the activity, and a 100% confidence indicates that they are certain they can perform the
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given task. Upsetting thoughts include thinking about unpleasant aspects of the caregiving
situation, viewing the caregiving situation as unfair, thinking about how much they have lost,
thinking about how much they are missing/giving up, and worrying about future problems.
Internal reliability for this measure is good (α = .80) and test-retest reliability has been shown to
be adequate (r = .76). The internal consistence of this measure, within the current study, was
excellent (α = .96). Skew and Kurtosis in this sample were within normal limits, indicating
acceptable normality of the data. One multivariate outlier was identified within the experimental
group; mean values of self-efficacy for controlling upsetting thoughts were substituted for this
participant’s responses, in order to maintain the highest possible sample size.
Covariate and demographic measures: Caregivers
Caregiver demographics. For descriptive purposes, caregivers provided information
about their age, ethnicity, marital status, household income, level of education and employment
outside of the home. They were also required to provide information about their relationship to
the care recipient, the number of years they have been caregiving, the amount of the care
recipient’s total care that they personally provide, as well as the specific ways in which they help
the older adult manage medications.
Depression Anxiety Stress Scale (DASS) – 21 item short form. The Depression Anxiety
Stress Scale - 21, is a 21-item measure that asks participants to describe their current level of
distress within the domains of depression, anxiety and stress (Lovibond & Lovibond, 1995).
Responses are scored on a 4-point Likert scale where 0 = Never and 3 = Almost Always. Higher
total scores in each domain, represent greater levels of subjective distress. The measure is broken
into three domains of function, Depression, Anxiety and Stress, which each contain 7 items.
Each subscale is calculated by summing the responses in that domain; cutoff score descriptions
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within each field range from normal, to extremely severe, with total possible scores on each
subscale ranging from 0-21. This scale has demonstrates good internal reliability; Depression α
= .94, Anxiety α = .87 and Stress α = .91. The DASS has also been shown to have good
convergent validity with other measures of depression and anxiety (BAI and BDI), and is
psychometrically sound across multiple populations both clinically and non-clinically based
(Antony, Bielig, Cox, Enns, & Swinson, 1998; Lovibond & Lovibond, 1995). In the current
study, the DASS-21 demonstrated good to excellent levels of internal consistency: Depression α
= .92, Anxiety α = .80 and Stress α = .90. Additionally, results revealed that the Depression
Subscale of the DASS was slightly positively skewed and kurtotic, while the Stress scale was
slightly positively kurtotic (Table 6). There was no evidence of outliers. No transformations were
completed to allow for greater interpretability of the main analyses.
Intervention Dosage: Login Access. The intervention website included an
administrative option that tracked the number of times an individual caregiver logged into the
site using their unique login ID and password. Using the “Slimstats” function within the
administrative access portion of the website, the total number of logins was found for each
individual participant. Only those caregivers who had logged into the intervention website, a
minimum of one time, were included in final analyses as treatment completers. Those who never
logged into the intervention website were considered treatment non-completers.
Intervention Dosage: Didactic Resource Access. The intervention website also tracked
whether or not an individual downloaded a handout or didactic video, how many times this
occurred, and at what time. Each PDF handout and didactic video was reviewed for usage
statistics and tied to an individual participant, using the “slimstats” function within the
administrative access portion of the website. The total number of times an individual
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downloaded each type of resource was summed. Thus, an individual could view a single PDF or
didactic video multiple times, and each occurrence was counted as a discrete event for that
resource. These viewing events were then summed within the four content areas to describe the
number of resource downloads/ views within the domains of “Medication Management,”
“Talking Together,” “Signs of Confusion, “ and “Healthcare Visits.”
Intervention Dosage: Narrative Video Access. Similar to the aforementioned usage
measures, the intervention website tracked whether or not an individual in the experimental
condition downloaded a narrative video, how many times this occurred, and when. Each
narrative video was reviewed for usage statistics and tied to an individual participant, using the
“Slimstats” function within the administrative access portion of the website. The total number of
times an individual downloaded each type of video was summed. Each viewing occurrence was
counted as a discrete event for that video resource. These viewing events were then summed
within the four content areas to describe the number of episode views within the domains of
“Medication Management,” “Talking Together,” “Signs of Confusion, “ and “Healthcare Visits.”
Covariate and demographic measures: Care recipients
Care recipient demographics. Caregivers were asked to provide several pieces of
information about the older adult for whom they provide care. Caregivers described the care
recipient’s current living arrangements, race/ethnicity, category of neurocognitive diagnosis and
were asked to check boxes with medical diagnostic categories that matched the concerns of their
care-recipient. Caregivers also reported the total number of prescription medications that their
care-recipient was prescribed, as well as the total number of over-the-counter medications this
individual utilized. Participants were not asked about the function of these medications, specific

Medication Non-Adherence and Dementia

59

names of the medications or dosages, in order to preserve care-recipient confidentiality for carerecipient protected health information.
HbLq Medication Risk Questionnaire. This 8- item measure is designed to assess
medication regimen complexity as well as risk for adverse drug events in older adults (ADEs).
Individuals are asked to report on various aspects of medication complexity and risk, by
selecting a “yes” or “no” response for each of the 8 risk factors for an ADE. A “yes” response is
coded as a one, while a “no” is coded as a zero. Item scores are summed to create an overall
medication complexity and risk score, with higher numbers indicating greater risk. The scale
contains questions regarding number of medications, number of prescribing physicians, number
of medical problems and pharmacies (Levy, 2003). This scale demonstrates adequate internal
consistency in original psychometrics studies (α = .69), with high test-restest reliability (κ > 0.6).
The current study demonstrates similar levels of internal consistence (α = .70) and is normally
distributed with minimal kurtosis and skew (Table 6). No outliers were identified and no
transformations were made based on the already normally distributed nature of the data.
Analogue Clinical Dementia Rating Scale (CDR). This measure was originally
developed as a structured clinical interview. The analogue CDR is scored on a five-point scale
that is meant to describe individuals without neurocognitive concerns (0) and with questionable
(0.5), mild (1), moderate (2), and severe (3) neurocognitive difficulties. The overall CDR score is
determined by a complex algorithm that takes into account items in six domains of functioning:
memory, orientation, judgment and problem solving, involvement in community affairs,
involvement at home and in hobbies, and personal care. In its original format, clinicians score
each domain of functioning, and are instructed to score each functional domain independently
from the others. Original levels of inter-rater reliability for this measure were high, with all
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domains ranging from .75 - .94. This scale was modified for the current study: all items were
given with the exact same instructions, but the caregivers were asked to rate their own
perceptions of the care-recipient’s level of impairment. Internal reliability of the measure
administered in this new format for the current study, was excellent (α = .93). Responses on this
measure demonstrated a normal distribution with minimal kurtosis and skew (Table 6). No
outliers were identified. As such, no transformations were made to the data and no data points
were removed.
Activities of Daily Living Form. Caregivers were asked to report on the current
functional deficits of the identified family member, using the Katz Activities of Daily Living
Form (ADL; Katz et al., 1963). This questionnaire asks caregivers whether care-recipients are
able to independently bathe, eat, toilette etc. Scores on this measure range from 0 to 6 with 0
being the highest level of impairment in ADLs (ADL; Katz, Ford, Moskowitz, Jackson, & Jaffee,
1963). This instrument was originally designed to be rated by a healthcare professionals but has
since been shown to be reliable (α = .78-.94) and valid when completed by family caregivers
(Sikkes, et al., 2010). This measure demonstrated excellent internal reliability in the current
study (α = .91), but was negatively skewed (Table 6). No outliers were identified and to
maintain interpretability of the results, no transformations of the data were completed.
Independent Activities of Daily Living. Caregivers were asked to report on their carerecipient’s ability to perform independent activities of daily living as measured by the
Independent Activities of Daily Living Scale (IADL; Lawton, Moss, Fulcomer & Kleban, 1982).
This is a 31 item measure which assesses 8 domains of functioning: Ability to use the telephone,
shopping, food preparation, housekeeping, laundering, obtaining transportation, responsibility
for own medications and finances. Scores on this measure range from 0 to 8, with a score of 0

Medication Non-Adherence and Dementia

61

indicating the greatest level of impairment. This instrument was originally designed to be rated
by a healthcare professionals but has since been shown to be reliable (α = .78-.90) and valid
when completed by family caregivers (Sikkes, et al., 2010). This measure demonstrated
acceptable levels of internal reliability in the current study (α = .64), but was positively skewed
and kurtotic (Table 6). No outliers were identified and to maintain interpretability of the results,
no transformations of the data were completed.
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Table 6
Psychometric Properties of Study Variables (n = 35 User Satisfaction; N =53 other Variables)

Variable

Mean

SD

Range

SE of
Skew

Skew

User Satisfaction

43.97

9.50

8-56

.40

-1.80

.78

4.90

.96

32.22

22.48

0-90

.33

.67

.64

-.21

.97

11.57

8.70

0-34

.33

.64

.64

-.12

.92

5.94

5.38

0-22

.33

1.02

.64

.65

.89

10.06

7.32

0-27

.33

.44

.64

-.72

.86

4.66

3.83

0-13

.33

.67

.64

-.86

.83

Morisky Medication
Adherence Scale

2.45

1.61

0-7

.33

.65

.64

-.06

.60

Stanford Patient
Communication Scale

3.24

1.81

0-5

.33

-.73

.64

.50

.70

Self-Efficacy For
Controlling Upsetting
Thoughts

62.35

30.18

0-100

.33

-.49

.64

-.95

.96

DASS: Depression
DASS: Anxiety
DASS: Stress

4.85
2.89
7.24

4.25
3.12
4.64

0-21
0-11
0-21

.33
.33
.33

1.32
.99
.98

.64
.64
.64

2.67
-.01
1.13

.92
.80
.90

Medication Risk HBLQ

3.87

.19

1-7

.33

-.13

.64

-.41

.70

Clinical Dementia
Rating Scale

1.45

.80

.5-3

.33

.75

.64

-.58

.93

Activities of Daily
Living

3.02

3.47

0-6

.33

.01

.64

-.70

.91

Independent Activities
of Daily Living

1.06

1.41

0-6

.33

1.74

.64

2.80

.64

Medication
Administration Hassles
Subscale:
Information Seeking
Subscale:
Safety Issues
Subscale:
Scheduling Logistics
Subscale:
Polypharmacy

SE of Kurtosis alpha
Kurtosis
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Data Analytic Strategy
Independent sample t-tests were used to evaluate between group differences in
satisfaction with each treatment strategy, post-intervention. A repeated measure MANOVA
assessed Condition * Time effects and the main effect of time on participant self-reported
hassles. Similarly, repeated measure ANOVA analyses assessed Condition * Time effects and
the main effect of time for the following dependent variables; patient-provider communication,
medication adherence and self-efficacy for controlling upsetting thoughts.
In order to achieve power of 0.80 for the primary analyses, at an alpha of .05, with a large
effect size (d = .80), a minimum of 26 participants were required at pre and post-intervention, in
each treatment group (Cohen, 1992). Thus, of the initially planned data analyses, the largest
sample size necessary was N = 52. This study is considered underpowered for testing mean
differences in scores (N = 35), due to attrition of the initially enrolled 53 participants. Because
the analyses were not modified to accommodate this small sample size, Cohen’s d and pwere
utilized in unison with p values to assess for statistical significant differences between groups
scores. Further, p value corrections for type one error were not utilized due to the underpowered
nature of this study.
No missing values were present in this data set. All responses to primary measures in the
pre-assessment and post-assessment were marked in the survey software as “required” items, due
to the anticipated difficulty in obtaining participants who qualified for the study, as well as the
potential dropout. As described above, all data were screened for high quality of responses. No
participants were removed due to low response quality, as all individuals fell within the
estimated highest on lowest time range of assessment completion. All data was checked for
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normality; no transformations were completed in order to allow for ease of interpretability.
Independent sample t-tests and chi square analyses were completed to assess for pre-treatment
equivalence, as described above. The narrative vignette and comparison didactic group were
approximately equivalent on all initially gathered demographic variables, but the comparison
didactic group began the intervention reporting a greater level of medication administration
hassles. In instances where outliers were identified, mean value substitution was utilized to
replace outlying values. Mean insertion based upon outlier data was infrequent and occurred in
less than 3% of cases.
Intervention Website Usage
In order to describe website usage patterns, resource access statistics were downloaded
and sorted by type of resource viewed (i.e. content area of resource) and the format of the
resource viewed (narrative video or didactic resource). Each participant’s resource usage was
coded using the cumulative number of views for each individual didactic video and narrative
resource, as opposed to a binary “viewed” or “not viewed” system. All participants who logged
into the intervention website, including those who did not complete assessment time point two,
were included in website usage analyses (control n = 19; experimental n = 18).
As shown in Table 7, when compared across treatment conditions, didactic comparison
group caregivers and narrative vignette caregivers, viewed approximately equivalent numbers of
didactic resources in the following intervention topic areas: “Medication Management,” “Talking
Together,” and “Causes of Confusion.” Caregivers in the narrative vignette group viewed a
greater number of PDF and expert video resources within the “Healthcare Visits” content area
than did comparison didactic group participants (didactic M = 1.84, SD = .2.17; narrative
vignette M = 2.39, SD = 2.68; p = .04; Cohen’s d = .23). A trend arose, but did not reach
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significance, when comparing the total number of PDF and didactic video resources viewed
between comparison didactic and narrative vignette group participants; narrative group
participants showed a non-significant trend toward viewing a greater total number of didactic
resources than the comparison didactic group (didactic M = 12.05, SD = 10.60; narrative M =
14.22, SD = 13.21; p = .07; Cohen’s d = .19). As described above, the PDF and expert video
didactics were available in both conditions. When caregivers were compared by treatment
condition on their total usage of all resources, including both didactic resources and narrative
video episodes (only available to the experimental group), caregivers in the experimental
condition showed a greater number of total views for all website resources (didactic M = 12.31,
SD = 10.99; narrative M = 27.00, SD = 23.64; p < .001; Cohen’s d = .83,)
Caregiver narrative video usage was also examined for descriptive purposes. As reported
in Table 8, participants in the narrative vignette condition showed the highest number of
narrative video views in the “medication management” content area (M = 3.44, SD = 3.20),
followed by “Talking Together” (M = 2.89, SD = 2.87), “Causes of Confusion” (M = 2.67; SD =
2.81) and “Healthcare Visits” (M = 2.39, SD = 2.59).
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Table 7
Number of Didactic Resource Views (PDF + Didactic Video) and Total Resources Viewed (PDF
+ Didactic Videos + Narrative Videos) per Content Area, across Conditions

Didactic
( n = 19)

Narrative
(n = 18)

F

P Value

Cohen’s d

Number of Didactic Resource
views; “Medication
Management” (M , SD)

3.00 (3.53)

4.39 (4.31)

.44

.51

.36

Number of Didactic Resource
Views; “Talking Together”
(M , SD)

3.00 (2.92)

3.22 (3.51)

2.32

.14

.07

Number of Didactic Resource
Views “Causes of Confusion”
(M , SD)

4.21 (3.43)

4.22 (3.69)

1.24

.27

0.0

Number of Didactic Resource
Views; “Healthcare Visits”
(M , SD)

1.84 (2.17)

2.39 (2.68)

4.78

.04*

.23

Variable

Total Didactic Resources
Viewed (M , SD)

12.05 (10.60) 14.22 (13.21)

3.61

.07

.19

Total number of All Resources
Viewed, Any Type (M , SD)

12.31 (10.99) 27.00 (23.64)

17.46

.00**

.83

* = p < .05., ** = p < .001
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Table 8
Description of Total Narrative Episode Viewing Incidents per Content Area

Content Area

M

SD

“Medication Management”

3.44

3.20

“Talking Together”

2.89

2.87

“Causes of Confusion”

2.67

2.81

“Healthcare Visits”

2.39

2.59
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Results

Primary Outcomes
Hypothesis one. Independent samples t-tests were used to test the hypothesis that
participants in the narrative vignette condition would report higher levels of satisfaction with the
intervention than participants in the comparison didactic group. As seen in Table 9, analyses
revealed that there were no significant differences between the narrative vignette and comparison
didactic condition on total intervention satisfaction scores (Control M = 45.33, SD = 7.81;
Experimental M =44.68, SD = 6.75; p = .46, Observed power = .08). Similarly, no significant
differences were found between groups on satisfaction levels with the intervention’s level of
convenience, level of interest it provoked, pace, tolerability or amount of information that was
presented. Although non-significant, a trend emerged with narrative group participants reporting
slightly higher levels of satisfaction with the intervention entertainment value (Control M = 5.11,
SD = 1.28; Experimental M =5.19, SD = 1.09; p = .15, Observed power = .08)
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Table 9
Comparison of Participant Intervention Satisfaction across Treatment Conditions

Variable

Didactic
( n = 18)

Narrative
(n = 17)

F

P
Value

Cohen’s
d

Power

Satisfaction Total (M , SD)

45.33 (7.81)

44.68 (6.75)

.56

.46

.09

.08

Satisfaction: Convenience
(M , SD)

5.94 (1.11)

5.75 (1.00)

.23

.63

.18

.13

Satisfaction: Entertainment
(M , SD)

5.11 (1.28)

5.19 (1.09)

2.17

.15

.07

.08

Satisfaction: Interesting
(M , SD)

5.50 (1.15)

5.75 (.93)

1.24

.28

.24

.17

Satisfaction: Fast (M , SD)

5.71 (1.07)

5.63 (1.09)

.02

.89

.07

.08

Satisfaction: Useful
(M , SD)

5.67 (1.24)

5.50 (1.10)

.31

.58

.15

.11

Satisfaction: Practical
(M , SD)

5.94 (.94)

5.56 (1.10)

.86

.36

.37

.28

Satisfaction: Tolerable
(M , SD)

5.72 (.90)

5.60 (1.03)

1.25

.27

.12

.10

Satisfaction: Information
(M , SD)

5.72 (1.45)

5.75 (1.00)

1.51

.23

.02

.06

* = p < .05.
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Hypothesis two. A repeated measures two-group, Time * Condition MANOVA, was
used to test the hypothesis that narrative vignette group participants would report greater
decreases in medication management hassles than participants in the comparison didactic
condition from pre-treatment to post-treatment (for variable means see Table 10). Results
indicate that the composite dependent variable, comprised of the change in four hassles subscales
from pre-treatment to post-treatment, was not significantly affected by treatment condition F (4,
30) = 1.63, p = .19, p = .18, achieved power = .44 (Table 11). Intervention dosage, as
measured by total number of discrete didactic and narrative resource viewing events, was
examined as a covariate in this model, but was not retained. Univariate analyses found nonsignificant results across tested subscales associated with small portions of the variance in
change: Hassles of Information Seeking F (1, 33) = .08, p = .78, p = .00, Observed Power =
.06; Hassles of Scheduling F (1, 33) = 1.25, p = .27, p = .04, Observed power = .19; Hassles of
Safety F (1, 33) = .01, p = .93, p = .00, Observed power = .05; Hassles of Polypharmacy F (1,
33) = .3.66, p = .07, p = .11, Observed Power = .46. Similarly, this analysis revealed a nonsignificant main effect of time on caregiver reported medication administration hassles F (4, 30)
= .89, p = .48, p = .11, achieved power = .25 (Table 11). Based on these results, hypothesis
two was not supported.
Hypothesis three. A repeated measures two-group, Time * Condition ANOVA, was
used to test the hypothesis that narrative vignette group participants would report a greater
increase in positive patient – provider communication behaviors, than participants in the
comparison didactic condition from pre-treatment to post-treatment. Results showed that
caregiver communication behaviors, from pre-treatment to post-treatment, were not significantly
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affected by treatment condition F (1, 33) = 2.74, p = .11, p = .08, Achieved power = .36 (Table
11). Based on initial group differences, the total medication administration hassles score was
examined for inclusion in this model as a covariate, but was not retained as a significant
covariate in the model. Similarly, intervention dosage, as measured by total number of discrete
didactic and narrative resource viewing events, was examined as a covariate in this model, but
not retained. This analysis also revealed a non-significant main effect of time on patient-provider
communication F (1, 33) = .22, p = .65, p = .01, Achieved power = .07 (Table 11). Overall,
there was no evidence to suggest that caregiver communication behavior was impacted
differently by treatment condition over time. Thus, hypothesis three was not supported.
Hypothesis four. A repeated measures two-group, Time * Condition ANOVA was used
to test the hypothesis that narrative vignette group participants would report a greater
improvement in medication adherence behaviors related to the care-recipients regimen, than
participants in the comparison didactic condition from pre-treatment to post-treatment. Results
showed that medication non-adherence, from pre-treatment to post-treatment, was not
significantly affected by treatment condition F (1, 33) = 2.83, p = .10, p = .08, Achieved power
= .37 (Table 11). Based on initial group differences, pre-treatment total hassles score was
examined for inclusion in this model as a covariate, but was not retained as significant.
Similarly, intervention dosage, as measured by total number of discrete didactic and narrative
resource viewing events, was examined as a covariate in this model, but was not retained.
Overall, there was no evidence to suggest that caregiver adherence to prescribed regimens was
impacted differently by treatment condition over time. This analysis also revealed a nonsignificant main effect of time on caregiver medication management F (1, 33) = .96, p = .34, p
= .03, Achieved power = .16 (Table 11). As a result, hypothesis four was not supported.
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Hypothesis five. A repeated measures two-group, Time *Condition ANOVA was used
to test the hypothesis that experimental treatment condition participants would report a greater
increase in self-efficacy for controlling upsetting thoughts about the caregiving situation, than
participants in the control didactic condition from pre-treatment to post-treatment. Results
showed that self-efficacy for controlling upsetting thoughts, from pre-treatment to posttreatment, was not significantly affected by treatment condition F (1, 33) = .09, p = .76, p =
.00, Achieved power = .06. Based on initial group differences, the total pre-treatment
medication administration hassles score was examined for inclusion in this model as a covariate,
but was not retained, due to non-significance. Similarly, intervention dosage, as measured by
total number of discrete didactic and narrative resource viewing events, was examined as a
covariate in this model, but was not retained. This analysis did, however, reveal a significant
main effect of time on caregiver self-efficacy for controlling upsetting thoughts about the
caregiving situation F (1, 33) = 8.07, p < .001, p = .20, Achieved power = .79. Examination of
pre/post-treatment means and standard deviations reveal this change occurred in the direction of
improved self-efficacy for controlling upsetting thoughts over time.
Hypothesis five exploratory analyses. Due to the apparent increase in self-efficacy for
controlling upsetting thoughts in both groups, over time, exploratory analyses were used to
assess the significance of these within group changes, and to determine whether one or both
groups was driving the significant result. Paired sample t-tests were computed to determine if
there was a change in Self-Efficacy for Controlling Upsetting thoughts within comparison
didactic group participants from pre-treatment to post treatment (Table 12). Results indicate that
the overall caregiver self-efficacy for controlling upsetting thoughts score did not change
significantly within the didactic group between pre-treatment and post-treatment. Although
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participants in the comparison didactic condition show marginal increases in total levels of Selfefficacy for controlling upsetting thoughts, as well as individual areas of self-efficacy (i.e.,
controlling thoughts about unpleasant aspects of care, fairness, their previous life, things they
have given up and worries about the future), these changes did not reach statistical significance.
Similarly, paired sample t-test were used to compare narrative vignette group participants
on self-efficacy for controlling upsetting thoughts at pre-treatment and post-treatment (Table 13).
Results indicate that caregiver self-efficacy improved significantly within the narrative vignette
group from pre-treatment to post-treatment. Caregivers in the narrative condition showed a
significant overall increase in self-efficacy for controlling upsetting thoughts from pre-treatment
(M = 62.95, SD = 33.55) to post treatment (M = 72.38, SD = 31.27), t(17) = -2.53, p =.02.
Specifically, participants in the narrative condition significantly increased in their self-efficacy
for controlling upsetting thoughts about unpleasant aspects of the caregiving situation (pretreatment M = 63.17, SD = 32.74; post treatment M = 72.47, SD = 31.71, t(17) = -2.18, p =.04;
Cohen’s d = .30) thoughts about caregiving being unfair (pre-treatment M = 62.23, SD = 36.00;
post treatment M = 73.11, SD = 33.95, t(17) = -2.11, p =.05; Cohen’s d = .32 ) and worries
about the future (pre-treatment M = 53.59, SD = 33.76; post treatment M = 62.17, SD = 33.57,
t(17) = -2.11, p =.05; Cohen’s d = .26). Although it did not reach statistical significance, there
was a trend toward improvement in controlling upsetting thoughts about the “how good life was
before caregiving,” (pre-treatment M = 66.12, SD = 37.88; post treatment M = 75.56, SD =
33.45, t(17) = -2.04, p =.06; Cohen’s d = .27). Overall, caregivers in the experimental group
demonstrated improved total self-efficacy for controlling upsetting thoughts, as well as improved
self-efficacy for controlling upsetting thoughts in several individual domains.
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Table 10
Pre and Post-Intervention Scores on Primary Outcome Measures across Treatment Condition

Didactic (n = 18)

Variable

Narrative (n = 17)

Pre- Treatment

Post- Treatment

Pre-Treatment

Post- Treatment

11.83 (10.06)

10.83 (8.20)

10.23 (7.67)

13.00 (7.70)

10.83 (8.31)
6.77 (6.57)
6.00 (4.77)

9.50 (7.09)
4.72 (4.10)
3.83 (4.16)

9.06 (7.96)
4.94 (4.39)
3.17 (3.32)

8.76 (8.68)
6.41 (4.03)
3.11 (3.52)

Omnibus Test: Stanford
Patient Communication
Scale (M, SD)

3.83 (.86)

3.52 (1.15)

2.90 (1.20)

3.09 (1.40)

Omnibus Test: Morisky
Medication Adherence
(M, SD)

2.56 (1.65)

2.11 (1.64)

2.23 (1.03)

2.35 (1.17)

Omnibus Test: SelfEfficacy for Controlling
Upsetting Thoughts
(M, SD)
* = p < .05.

62.67 (27.21)

70.28 (28.82)

62.95 (33.55)

72.38 (31.27)

Omnibus Test:
Medication Hassles
Information
Seeking (M, SD)
Scheduling
(M, SD)
Safety (M, SD)
Polypharmacy
(M, SD)
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Table 11
Repeated Measures Multivariate and Univariate Analysis of Variance for Primary Outcome
Variables



Variable

df

MS

F

p

p

Observed
Power


Omnibus Test:
Medication Hassles
Time
Condition * Time

4
4

12.06
35.11

.89
1.63

.48
.19

.11
.18

.25
.44

Omnibus Test:
Patient Communication
Time
Condition * Time

1
1

.08
1.06

.22
2.74

.65
.11

.01
.08

.07
.36

Omnibus Test:
Medication Adherence
Time
Condition * Time

1
1

.47
1.38

.96
2.83

.34
.10

.03
.08

.16
.37

Omnibus Test: SECUT
Time
Condition *Time

1
1

1268.49
14.36

8.07
.09

.00**
.76

.20
.00

.79
.06

Note: SECUT = Self Efficacy for Controlling Upsetting Thoughts. * = p < .05; ** = p < .001.
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Table 12
Secondary Analyses: Within Subjects Comparison of Didactic Group Participants on Pretreatment and Post-treatment Self-Efficacy (n = 18)

Pre-Treatment

Outcome

Post-Treatment

t

df

p

Cohen’s
d

-17.41, 2.18

-1.64

17

.12

.28

24.62

-18.16, 7.67

-.92

17

.37

.23

74.67

27.58

-17.03, 3.73

-.35

17

.19

.24

31.78

69.27

34.20

-19.04, 4.03

-1.37

17

.19

.23

62.83

31.51

69.72

31.26

-18.71, 4.93

-1.23

17

.24

.23

49.94

33.62

61.44

34.68

-26.79, 3.79

-1.56

17

M

SD

M

SD

62.67

27.21

70.28

28.82

SECUT:
Unpleasant
Aspects of Care

70.78

25.43

76.27

SECUT: Unfair

68.00

28.87

SECUT:
Previous life

61.78

SECUT: Gave
up for care

SECUT: Total

SECUT:
Worries about
Future

95% CI for
Mean
Difference

Note. SECUT = Self- Efficacy for Controlling Upsetting Thoughts, * = p < .05

.13

.35
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Table 13
Secondary Analyses: Within Subjects Comparison of Narrative Group Participants on Pretreatment and Post-treatment Self-Efficacy (n = 17)

Pre-Treatment

Outcome

Post-Treatment

t

df

p

Cohen’s
d

-17.32, -1.52

-2.53

16

.02*

.30

32.71

-18.34, -.241

-2.18

16

.04*

.36

73.11

33.95

-19.81, .05

-2.11

16

.05*

37.88

75.76

33.45

-19.68, .04

-2.04

16

.06

.27

61.64

36.97

68.71

35.86

-15.99, 1.87

-1.68

16

.11

.23

53.59

33.76

62.17

33.57

-17.22, 04

-2.11

16

.05*

.26

M

SD

M

SD

62.95

33.55

72.38

31.27

63.17

32.74

72.47

SECUT:
Unfair

62.23

36.00

SECUT:
Previous life

66.12

SECUT: Gave
up for care

SECUT: Total
SECUT:
Unpleasant
Aspects

SECUT:
Worries about
Future

95% CI Mean
Difference

Note. SECUT = Self- Efficacy for Controlling Upsetting Thoughts, * = p < .05

.32
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Discussion

Summary of Results
This study assessed the efficacy of two differing online health education interventions.
Both conditions were designed to improve medication management and related healthcare
behaviors in informal caregivers of older persons with dementia. The didactic comparison
condition contained a series of downloadable PDF “Handouts” with information about managing
medications, attending a healthcare visit, causes of confusion in older adults, and communication
with the older loved ones. Each section included one video of an expert providing information in
traditional didactic voice. The narrative vignette condition included the same content as above,
with additional web episode storylines that showed caregivers interacting with their loved one,
and problem solving concerns in each of the aforementioned domains. The current study
introduced one of very few health oriented interventions targeting informal dementia caregivers
(George & Steffen, 2015; Kamimura, Ishiwata & Inoue, 2012).
Although this study presented with challenges, such as limited sample size and
correspondingly low power, several significant findings emerged in the data. Firstly, caregivers
in the narrative vignette condition showed more thorough usage of materials on the intervention
website than those in the didactic condition. Participants in the narrative condition viewed more
didactic resources (PDF + expert video) in the area of “Healthcare Visits,” than the comparison
didactic group. Although there were more total resources available in the experimental group,
the data suggests that caregivers in this condition fully utilized this additional information;
narrative group participants viewed more available links, in total, than those in the comparison
didactic group. Finally, a non-significant trend emerged, suggesting that caregivers in the
narrative condition might view more didactic resources, overall, than individuals in the
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comparison condition.
Primary analyses revealed that there were no significant differences between the narrative
vignette and comparison didactic groups on their reported levels of satisfaction with the
intervention, after treatment was completed. In addition, there were no Time * Condition effects
on medication hassles, communication with healthcare providers, medication management
adherence, or self-efficacy for controlling upsetting thoughts. Analyses revealed a significant
main effect of time on self-efficacy for controlling upsetting, across condition. Nevertheless, the
primary hypotheses were not supported.
Secondary analysis for this study revealed a number of significant results. Within group
comparisons of narrative vignette participants showed that this group improved significantly in
their self-efficacy for controlling upsetting thoughts about the caregiving situation from preintervention to post-intervention. Although trends existed, comparison didactic group
participants did not see the same significant within-group gains on self-efficacy, over time.
These points are considered below, in detail, and the study is reviewed for current strengths,
limitations and future directions.
Sample Description
This sample of caregivers was comprised of predominately Caucasian, middle-aged
women, caring for a parent who was diagnosed with Alzheimer’s disease. Of note,
approximately 38% of caregivers knew that their loved one was diagnosed with a dementing
illness, but did not know the exact diagnosis related to this impairment. Caregivers in this
sample were managing an average of 11 medications as a part of the care-recipient’s daily
regimen. These individuals were highly educated, middle class, and caring for moderately
impaired older adults, and were reporting a moderate level of hassles related to managing the
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care-recipient’s medications.
The current study sample exhibits a number of strengths and areas for growth. In
general, caregivers in this data set accurately represented overall demographics for caregivers in
the U.S. in the domains of age and care-recipient diagnosis (Alzheimer's Association and
National Alliance for Caregiving, 2004). One area of growth in this study, as well as the majority
of caregiver research, is obtaining a more ethnically diverse sample of participants (Reinhard,
Given, Petlick, & Bemis, 2008). Despite high effort to recruit non-white caregivers, with
particular recruitment attention given to the African American community, the majority of
caregivers in this study were Caucasian. Similarly, over half of the caregivers reported a
household income above $50,000 per year, and the majority had completed the equivalent of a
college degree. It is possible that caregivers in lower income communities with differing levels
of education may perceive the online nature of the study as a barrier, despite the growing trend
toward increased internet access in these communities (Cohen & Adams, 2009). Thus, although
this recruitment difficulty is consistent in the literature (Reinhard, Given, Petlick, & Bemis,
2008) it presents limitations to the generalizability of these results to non-white, lower income
and differently educated communities.
Pre-Treatment Group Equivalence. Narrative vignette and comparison didactic group
participants were approximately equivalent on all pre-treatment demographic variables. Both
groups were similar in regards to symptom presentations on primary outcome measures, with the
exception of three significant differences. Caregivers in the comparison didactic condition began
the intervention with higher levels of self-reported medication management hassles; they
reported hassles approximately 10 points above those of caregivers in the experimental group,
out of a possible 120 points (Travis, Kao, & Acton, 2005). Didactic group caregivers reported
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more polypharmacy related concerns at time one, such as keeping multiple prescriptions filled
and managing prescriptions by multiple providers. They also endorsed being more hassled by
medication issues related to safety, such as recognizing adverse side effects in the care recipient
and knowing how to give the medication safely. These initial discrepancies could have impacted
the ability to detect between-group differences. Because caregivers in the didactic condition
reported higher initial levels of hassles, they had greater room for improvement during the
intervention study. Conversely, the experimental group would experience a “floor effect,” and
have significantly lower room for improvement throughout the intervention. This failure in group
equivalency may have reduced the ability of the study to find significant between group
differences on changing levels of hassle pre and post-intervention.
Analysis of Dropout. Participant dropout in the current study was approximately 34%
across both treatment conditions. No significant differences arose in the number of participants
who dropped out of treatment between the comparison didactic condition and the narrative
vignette condition. Similarly, there were no differences in ethnicity, income, level of education,
level of care provided, or on the multiple indicators of subjective distress between the treatment
completers and non-completers. Thus, the intervention exhibited a strength in that once
participants were enrolled in the study, the treatment was tolerated equivalently well across
multiple caregiver demographic groups.
Significant differences were found in participant dropout on care-recipient levels of
impairment. Those who dropped out of treatment were providing care to persons who were less
impaired than those who completed the intervention study, as measured by the analogue CDR
and ability to complete ADLs. One hypothesis for this discrepancy is differing caregiver
perceptions about level of need for treatment, between those providing care for more impaired
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and less impaired elders. Multiple behavioral health models, such as the Health Belief Model
and the Protection Motivation Theory, postulate, and have shown good evidence, that
intervention participants must first believe that they are at risk for a particular concern, before
they are effectively able to consider it as a relevant problem, and engage in treatment for this
difficulty (Abraham & Sheeran 2004; Norman, Boer & Seydel, 2005). It is possible that
caregivers providing aid to those with more impairment saw the intervention as more relevant to
their current problems, whereas those providing care to an older adult with less impairment did
not see the intervention as germane to their current difficulties. If true, this is unfortunate, as
most neurocognitive disorders are progressive (Alzheimer’s Association, 2012). By the very
nature of neurocognitive illness, care-recipient level of impairment will increase over time and
topics that were initially less applicable may rapidly become necessary areas of focus for the
caregiver.
Lastly, it is important to note that caregivers who were expressing a greater degree of
medication related hassles and poorer medication management adherence were more likely to
drop out of treatment. If primary analyses had found significant differences between treatment
groups on these outcome variables, further examination would be required to ensure that
differential dropout did not occur between conditions, and artificially indicate treatment efficacy
that could be attributed to dropout. As noted below, between group differences did not arise,
however, thus negating the need for this inquiry. In addition, this finding raises concern of
intervention tolerability for individuals that are most in need of treatment. Although the
intervention was tolerated well by multiple demographic groups, it may have been more difficult
to complete for individuals with a higher severity of medication related concerns.
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Hypothesis 1 Discussion
Hypothesis one postulated that participants in the narrative vignette condition would
show greater levels of satisfaction with the intervention, than participants in the didactic
comparison condition, at the post-treatment assessment. No significant differences were found
between group levels of satisfaction. Intervention related satisfaction scores were high for both
conditions, in the mid-forties, out of a total of 56 possible points. On average, participants
reported that they were “satisfied,” or “very satisfied,” in most domains of the intervention,
including the tolerability of treatment. The tolerability of an intervention is a critical variable in
influencing participant retention in psychological and behavioral health related interventions, as
well as participant treatment engagement (Epstein, Thomson, Collins, & Pancella, 2009). It is
especially noteworthy that both groups found the interventions to be equally tolerable, as the
narrative condition contained a greater number of available video resources for treatment. Thus,
participants in the narrative condition viewed larger numbers of treatment materials and reported
similar satisfaction levels with the intervention, indicating that the increased level of materials
may not have been a significant burden on caregiver time. This is relevant in the current
caregiver population, as these individuals typically report being pressed for time, especially
members of a sandwich generation, who provide care for both children and older loved ones
(Steffen et al., 2002).
Hypothesis 2 Discussion
Hypothesis two posited that caregivers in the narrative condition would show greater
decreases than the comparison didactic group on medication administration hassles, over time.
There was no significant Time * Condition effect on caregiver self-reported hassles, nor was
there a significant main effect of time on this variable. There are a number of possible reasons
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for this finding. As mentioned above, the groups did not begin at an equivalent level of
medication administration hassles; the comparison didactic group initially reported greater levels
of hassle, thus widening the range of possible change scores, and decreasing the possibility that
the narrative group could show greater levels of change on this variable. Once again, this study
was also somewhat underpowered. Although every effort was made to obtain the initially
proposed sample size of N=53, only 35 participants successfully completed the study. To find
any significant differences, regardless of directionality, the effect size would have to be within
the “large” categorization of current statistical recommendations (Cohen, 1992). Analyses of the
total medication administration hassles and hassles subscale changes across group never reached
an effect size that would be considered “large.” As a result, it is unlikely that current statistical
analyses would have the power to find a significant result. Lastly, it is also possible that this was
a correct acceptance of the null hypothesis, that treatment condition did not differentially impact
caregiver medication administration hassles over time.
Hypothesis 3 Discussion
Hypothesis three predicted that the narrative group participants would show a greater
increase in self-reported positive communication behaviors with medical providers, compared to
the comparison didactic condition, over time. There was no significant Time * Condition effect
or main effect of time on this variable. Once again, possible reasons for these results include the
low power available for study, due to a small sample size. Effect size analyses revealed only a
small pfor this result, and an observed power of .36, indicating a 36% likelihood of detecting
statistical significance and correctly rejecting the null hypothesis if p < .05.
In addition, it is also possible that neither treatment group had the opportunity to reassess their current communication behaviors with medical providers, in real medical
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appointments, within the month-long time period of the study. As such, there may not have been
an opportunity for caregivers to notice a change in their behaviors within this context. Of course,
the final possibility remains that this study correctly accepted the null hypothesis, that there was
no differential intervention group impact on patient-provider communication over time.
Hypothesis 4 Discussion
Hypothesis four predicted that narrative group participants would show greater
improvements in medication adherence behaviors for care-recipient medication regimens,
compared to didactic group participants, over time. Analyses revealed that there was no
significant Time * Condition effect nor was there a main effect of time on medication adherence
behaviors. Once again, this analysis suffers from the same low statistical power and small effect
size as was present in previous analyses. The corresponding difficulty in finding statistically
significant results remains a consideration in this analysis (Cohen, 1992). As mentioned above,
for hypothesis 3, it is also possible that the month-long intervention progression did not provide
caregivers with adequate time to have re-adjusted their medication management behaviors and to
report on said adjustments. This might be especially true in cases where caregivers exhibited the
majority of their resource views in the final week of the intervention. Again, the final possibility
also remains that this study correctly accepted the null hypothesis, that there was no differential
intervention group impact on caregiver medication adherence behaviors, over time.
Hypothesis 5 Discussion
Hypothesis five postulated that narrative group participants would show greater increases
in self-efficacy for controlling upsetting thoughts related to the caregiving situations, compared
to didactic group participants, over time. Analyses revealed a non-significant Time * Condition
effect on self-efficacy, but a significant main effect of time on caregiver self-efficacy for
controlling upsetting thoughts. Thus, the composite improvement scores in both groups’ level of
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self-efficacy, was found to be significant. Once again, however, it is possible that due to the
small sample size, the correspondingly low power and the small effect sizes observed for this
analysis, the study did not have the power necessary to be able to detect statistically significant
differences between groups. This assertion may be correct, as trends in the data suggest that
although both groups show increased self-efficacy for controlling upsetting thoughts over time,
the narrative condition exhibits greater trends in this direction.
Secondary analyses for hypothesis 5 revealed a significant within-group effect in the
narrative condition; caregivers receiving this treatment showed significant increases in total
levels of self-efficacy for controlling upsetting thoughts from pre-intervention to postintervention. Specifically, participants in the narrative condition reported improved ability to
control upsetting thoughts about “how unfair the caregiving situation is,” “unpleasant aspects of
the caregiving situation,” and “worries about the future.” Based on these findings, it is possible
that caregivers in the narrative group were effectively able to build self-efficacy through
vicarious experiences of similar others in the narrative web episodes (Bandura, 1977; Bandura,
1982; Bandura, 1994). This is a promising finding, as improved self-efficacy has been linked to
one’s ability to persist in tasks despite obstacles, and to learning new behaviors (Bandura, 1982;
Bandura, 1994; Bandura, 1997). As a result, this increase in self-efficacy may correlate with
other long-term improvements in health management domains of caregiving.
Despite the possibility that this improvement may be attributable to the intervention, it is
also possible that internal threats to validity, such as maturations, regression toward the mean
and repeated assessment, have impacted this finding (Kazdin, 2003). It is difficult, without
further data, to attribute this finding exclusively to the impact of the intervention. A “notreatment” or waitlist control would be beneficial in further exploring this result.
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Evaluation of Research Methodology
Strengths. This study included several novel components that served as strengths and
useful contributions to the present state of caregiving literature. Firstly, the intervention
developed for this manuscript was one of very few health education treatments that focused on
care dyads of a person with cognitive impairment (Banning, 2009; Conn et al., 2009). Current
studies meeting these criteria, often lack clear theoretical underpinnings in their intervention
development, and only include older adults with minimal cognitive concerns (Banning, 2009;
Conn et al., 2009). The present intervention, however, has clear theoretical groundings in
Bandura’s Social Cognitive Theory, while including caregivers of more impaired elders. In
addition, this is the first randomized health education intervention developed to focus largely on
caregivers. The majority of current studies focus on healthcare modifications for the cognitively
impaired older adult, while entirely neglecting the likelihood that there may be an involved
informal care partner (Kamimura, Ishiwata & Inoue, 2012).
In addition, the current intervention is the first health education treatment available to
caregivers in an online format. This is beneficial, as the number of individuals using online
resources, across generations, continues to increase (Cohen & Adams, 2009; Pew Research
Center, 2011). Those in lower income communities also report increasing access to technology
and the internet through the use of smart phones (Cohen & Adams, 2009), and most individuals
who seek out healthcare information use online searches, at some point during the process (Pew
Research Center, 2011). Finally, many studies show that caregivers have increased timeconstraints when compared to similar non-caregiving individuals (Schulz & Martire, 2004). The
online availability of interventions may decrease the time investment necessary for caregivers to
easily obtain aid.
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Another strength of the intervention is the flexible content approach. Caregivers in this
study were able to log into the website at any time of day and spend as much time as they
believed necessary on the intervention website. In addition, they were able to select any content
area and any video or PDF resources that interested them as a part of their own individualized
treatment program. The tailored and individual specific nature of this intervention is a
significant asset, as psychological treatment literature suggests that this is linked to increased
retention of participants as well as improved outcomes (Epstein, Thomson, Collins, & Pancella,
2009; Epstein, Collins, Thomson, & Pancella, 2007; Epstein & McGaha, 1999).
Limitations & Future Directions. The present study also had several limitations. In
general, the sample size was lower than necessary to obtain power sufficient for detecting
statistically significant changes between groups. In addition, secondary analyses lack a
comparison group, such as a no-treatment control or a waitlist control. Although this study
included a narrative condition and comparison didactic condition, there was no way to discern if
within group changes would have occurred without any form of intervention from the
researchers. It is difficult to positively attribute within-group changes over time to an
intervention effect rather than to threats to internal validity such as multiple assessment or
maturation. Further, many of the currently measured medication and healthcare related
behaviors may be low base-rate events and as such, ideal measurement of change should occur
over a period of time that is greater than one month. Future studies that seek to replicate and
explore these findings through longitudinal measurement and may wish to include a third, no
treatment control group, or waitlist control group that can be used as a comparison.
In addition, this study may have reduced external validity in caregivers who are nonwhite, lower income or who demonstrate lower educational attainment. It is possible that the
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decreased level of recruitment for these individuals reflects a bias in these communities for lower
access to technological resources (Pew Research Center, 2011), or it may reflect the traditional
pattern of these underserved populations to show lower general engagement with healthcare and
health related interventions, based on historical interactions with healthcare communities
(Commission on Social Determinants of Health, 2008; Office of Minority Health, 2011). Future
studies may benefit from anticipating these potential recruitment barriers, and remedy this by
singularly targeting individuals in these underserved communities. Similarly, future studies may
explore the current barriers to technological access and eliminate these by providing other
avenues to internet resources (i.e. library cards or rented tablets).
Other areas for growth may include attempts to utilize this intervention in spousal
caregivers, caregivers of persons without dementia, and exploring intervention response between
rural and urban caregivers. It would also be beneficial to identify the most salient intervention
components contributing to caregiver improvement over time. As is traditional with the
trajectory of most early intervention trials, future studies should seek to establish effectiveness,
rather than efficacy, in larger populations that includes a broader swath of caregivers (Kazdin,
2003). Dismantling trials, after establishing efficacy of the intervention, may be useful in
determining the “active ingredients,” involved in producing positive caregiver change (Kazdin,
2003). Because this study occurred over a relatively brief time frame (1 month), future research
may further benefit from extending the amount of follow-up contact and assessment points as
well as including a qualitative component regarding caregiver’s experiences during the
intervention trial.
Clinical Considerations. The current finding that narrative intervention participants saw
improved self-efficacy for controlling upsetting thoughts, has several clinical implications. This
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noted increases in self-efficacy could have benefits related to improved mood management in
caregivers (George & Steffen, 2015), increased ability to tolerate distress in the caregiving
situation, ability to persist in learning new behaviors, (Bandura, 1977; Bandura, 1982; Bandura,
1994), and may be linked to other positive health management behaviors for the older loved one.
Improving caregiver self-efficacy for controlling upsetting thoughts may have other unforeseen
positive consequences, such as reduced need for caregiver utilization of psychotropic
medications (George & Steffen, 2015). Clinical access points for caregiver introduction to this
intervention, may include Emergency Departments, which often serve as primary care for
underserved populations (Commission on Social Determinants of Health, 2008) or primary care
clinics, the first contact point for older adults and caregivers who are noting cognitive concerns
(Boise, Neal, & Kaye, 2004; Forester & Oxman, 2003).
Conclusions
This study investigated the efficacy of an online health education intervention, designed
to improve caregiver medication management of a cognitively impaired care-recipient’s
medication regimen. Women caring for an older generation, cognitively impaired loved one,
were randomized to one of two treatment conditions; the narrative vignette group or the didactic
comparison condition. Participants in this study were asked to complete pre-assessment
measures assessing caregiver medication administration hassles, patient-provider
communication, medication management adherence, and self-efficacy for controlling upsetting
thoughts. Afterwards, they engaged in a 1-month online health education intervention, and filled
out similar post-assessment questionnaires directly following completion of the intervention.
Strengths of this study include targeting a novel population for medication management in older
adults with dementia, creation of a flexible online format that allowed caregivers to explore
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health education content areas of most interest to them, and a theoretical basis in Social cognitive
theory.
The findings of this study were mixed and require further future exploration. Although
the didactic and narrative treatment groups did not differ from one another on improvement in
the aforementioned areas, there was a significant main effect of time on caregiver self-efficacy
for controlling upsetting thoughts. Participants in the narrative vignette condition, specifically,
showed significant overall improvement in self-efficacy for controlling upsetting thoughts, over
time. There were no differences in intervention group levels of satisfaction at post-treatment,
suggesting similar levels of tolerability between conditions.
Overall, this study provides the groundwork necessary implementation of health
education interventions in care dyads. Future research should seek to replicate these findings,
while including a no-treatment or waitlist control for comparison to the already developed
treatment conditions. In addition, future studies would benefit from exploring the external
validity of this intervention in underserved populations, broadening the possible treatment
populations, and completing dismantling studies to determine the effective components of the
present health education treatment.

Medication Non-Adherence and Dementia

92
References

Abraham, C., & Sheeran, P. (2004) Implications of goal theories for the theories of reasoned
action and planned behaviour. Current Psychology, 22, 218-233
Alzheimer's Association and National Alliance for Caregiving. Families care: Alzheimer's
Caregiving in the United States. Chicago, IL: Alzheimer's Association and National
Alliance for Caregiving; 2004.
Alzheimer’s Association. (2011). Changing the trajectory of Alzheimer’s Disease: A
national imperative. Washington DC: Public Policy Office.
Alzheimer’s Association. (2012). Types of Dementia retrieved from
http://www.alz.org/dementia/types-of-dementia.asp.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders
(4th ed., text rev.). Arlington, VA: Author.
American Psychiatric Association. (2010). Practice guideline for the treatment of patients with
Alzheimer's disease and other dementias. Arlington (VA): American Psychiatric
Association (APA).
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental
Disorders (Fifth ed.). Arlington, VA: American Psychiatric Publishing. pp. 5–25.
Aneshensel, C. S., Pearlin, L. I., Mullan, J. T., Zarit, S. H., & Whitlatch, C. J. (1995). Profiles in
caregiving: The unexpected career. San Diego, CA US: Academic Press.
Antony, M., Bielig, P., Cox, B., Enns, M., & Swinson, R. (1998). Psychometric properties of
the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical
groups and a community sample. Psychological Assessment, 10, 176-181.
Arlt, S., Reinhard, Linder., Rosler, A., & Von Rentelnkruse. (2008). Adherence to medication
in persons with dementia. Drugs and Aging, 12, 1033-1047.
Arnold, M. (2008). Polypharmacy and older adults: A role for psychology and psychologists.
Professional Psychology: Research and Practice, 39, 283-289.
Aspinall, S., Sevick, M. A., Donohue, J., Maher, R., & Hanlon, J. T. (2007). Medication errors
in older adults: A review or recent publications. American Journal of Geriatric
Pharmacotherapy, 5, 75-84.
Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change.
Psychological Review, 84, 191-215.

Medication Non-Adherence and Dementia

93

Bandura, A. (1982). Self-efficacy mechanism in human agency. American Psychologist, 37, 122
147.
Bandura, A. (1994). Self-efficacy: The exercise of control. New York: Freeman.
Bandura, A. (1998). Health promotion from the perspective of social cognitive theory.
Psychology and Health, 13, 623-649.
Bandura, A. (2001). Social cognitive theory: An agentic perspective. Annual Review of
Psychology, 52, 1–26.
Bandura, A. (2004). Social cognitive theory for personal and social change by enabling media.
In A. Singhal, M. J. Cody, E. M. Rogers, & M. Sabido (Eds.), Entertainment
education and social change: History, research, and practice (pp. 75-96). Mahwah, NJ:
Lawrence Erlbaum.
Banning, M. (2009). A review of interventions used to improve adherence to medication in
older people. International Journal of Nursing Studies, 46, 1505-1515.
Barat, I., Andreasen, S., & Damsgaard, E. (2001). Drug therapy in the elderly: What doctors
believe and what patients actually do. Journal of Clinical Pharmacology, 51, 615-622.
Barrouillet, P., Bernardin, S., Portrat, S., Vergauwe, E., & Camos, V. (2007). Time and
cognitive load in working memory. Journal of Experimental Psychology: Leanring,
Memory and Cognition, 33, 570-585.
Bates, D. W. (2007). Preventing Medication Errors: A Summary. American Journal of Health
Systems Pharmacy, 64, 3-9.
Beck, A.T., Rush, A. J., Shaw, B. & Emery, G. (1979). Cognitive therapy of depression. NY:
Guilford Press.
Beery, S. D., Quach, L., Proctor-Gray, E., Kiel, D. P., Wenjun, L., Samelson, E. J., & Lipsitz,
L. A. (2010). Poor Adherence to medication may be associated with falls. Journal
Of Gerontology, 5, 553-558.
Bergman-Evans, B. (2006). AIDES to improving medication adherence in older adults.
Geriatric Nursing, 24, 174-182.
Bellg, A. J., Borrelli, B., Resnick, B., Hecht, J., Minicucci, D. S., Ory, M., … Czajkowski, S.
(2004). Enhancing treatment fidelity in health behavior change studies: best practices and
recommendations from the NIH Behavior Change Consortium. Health Psychology, 5,
443-451.

Medication Non-Adherence and Dementia

94

Blalock, S. J., Byrd, J. E., Hansen, R. A., Yamanis, T. J., Katherine McMullin, K., DeVellis, B.
M… & Jordan, J. M. (2005). Factors associated with potentially inappropriate drug use
in rural community dwelling older adults. The American Journal of Geriatric
Pharmacotherapy, 3, 168-179.
Boise L., Neal, M. B., Kaye, J. (2004). Dementia assessment in primary care: results from a
study in three managed care systems. Journal of Gerontological Biological Science and
Medical Science, 59, 621–626.
Bouvy, M., Eibert, R., Heerdink, R., Urquhart, J., Diedericke, E., Grobbee, S… & Leufkens, L.
(2003). Effect of a pharmacist-led intervention on diuretic compliance in heart failure
patients: A randomized controlled study. Journal of Cardiac Failure, 9, 404-412.
Brodaty, H., Green, A., & Koschera, A. (2003). Meta-analysis of psychosocial interventions for
caregivers of people with dementia. Journal of the American Geriatrics Society, 51,
657-664.
Brus, H., Van de Laar, M., Taal, E., Rasker, J., & Wiegman, O. (2000). Determinants of
compliance with medication in patients with rheumatoid arthritis: The importance of
self-efficacy expectations. Patient Education and Counseling, 3, 57-64.
Burke M. M., Laramie, J. A. Primary care of the older adult: a multidisciplinary approach. St.
Louis: Mosby; 2000.
California State Board of Pharmacy. (2003). Drug Therapy Considerations in Older Adults.
California State Board: Communication and Public Education Committee.
Carlson, M. C., Fried, L. P., Xue, Q. L., Tekwe, C., Brandt, J. (2005). Validation of the Hopkins
Medication Schedule to identify difficulties in taking medications. Journal of
Gerontological and Biological Scientific Medicine, 60, 217–223.
Carnahan R. M., Lund B. C., Perry P. J., Chrischilles E. A. (2004). The concurrent use of
anticholinergics and cholinesterase inhibitors: Rare event or common practice? Journal
of American Geriatrics Society, 52, 2082-2087.
Cassie KM, Sanders S. Familial caregivers of older adults. In: Cummings SM, Kropf, Nancy P,
eds. Handbook of Psychosocial Interventions with Older Adults: Evidence-Based
Approaches. Philadelphia, PA: Haworth Press; 2008:293-320.
Centers for Disease Control and Prevention and The Merck Company Foundation. (2007). The
state of aging and health in America. Available at www.cdc.gov/aging. Accessed July 8,
2012.

Medication Non-Adherence and Dementia

95

Clifford, S., Barber, N., Elliott, R., Hartley, E., & Home, R. (2006). Patient-centered advice is
effective in improving adherence to medicines. Pharmacology World Sciences, 28, 165170.
Commission on Social Determinants of Health, (2008). Closing the gap in a generation: health
equity through action on the social determinants of health. Final Report of the
Commission on Social Determinants of Health. Geneva, World Health Organization.

Coday M., Boutin-Foster C., Goldman Sher T., Tennant J., Greaney M. L., & Saunders S. D.
(2005). Strategies for retaining study participants in behavioral intervention trials:
Retention experiences of the NIH behavior change consortium. Annals of Behavioral
Medicine. 29, 55–65.
Cohen J. Taking Medication: Special Concerns in Older Adults. PsychCentral. 2001 Oct.
Available at http://psychcentral.com/library/meds_older.htm. Last updated 9/7/06.
Cohen, M. (2008). Interdisciplinary Treatment Planning: Principles, Design, Implementation.
Hanover Park, IL: Quintessence Pub Co.
Cohen R. A., & Adams P. F. Use of the Internet for health information: United States, 2009.
NCHS data brief, no 66. Hyattsville, MD: National Center for Health Statistics. 2011.
Col N., Fanale J. E., Kronholm P. (1990). The role of medication noncompliance and adverse
drug reactions in hospitalizations of the elderly. Archives of Internal Medicine, 4, 841845
Committee on Health Literacy. Health Literacy: A Prescription to End Confusion. Washington,
DC: National Academic Press; 2004.
Conn, V. S., Hafdahl, A. R., Cooper, P. S., Ruppar, T. M., Mehr, D. R., & Russel, C. L. (2009).
Interventions to improve medication adherence among older adults: A meta-analysis of
adherence outcomes among randomized controlled trials. The Gerontologist, 49, 447462
Coon, D. W., Thompson, L., Steffen, A., Sorocco, K., & Gallagher-Thompson, D. (2003). Anger
and depression management: Psychoeducational skill training interventions for women
caregivers of a relative with dementia. The Gerontologist, 43, 678-689.
Coon, D. W., Ory, M., & Schulz, R. (2004). Family caregivers: Enduring and emergent themes.
In D. W. Coon, D. Gallagher-Thompson & L. W. Thompson (Eds.), Innovative
interventions to reduce dementia caregiver distress: A clinical guide (pp. 3-27). NY:
Springer.

Medication Non-Adherence and Dementia

96

Dijkstra W., Smit J. H., Comijs H. C. (2001). Use of social desirability scales in research
among the elderly. Quality & Quantity, 35, 107–115.
DiMatteo, M. R., Giordani P. J., Lepper, H. S., & Croghan, T. W. (2002). Patient adherence and
medical treatment outcomes: a meta-analysis. Medical Care, 40, 794–811
Douglas, A., Letts, L., & Richardson, J. (2011). A systematic review of accidental injury from
fire, wandering and medication self-administration errors for older adults with and
without dementia. Archives of Gerontology, 52, 1-10.
D’Zurilla, T. (1986). Problem solving therapy: A social competence approach to clinical
intervention. Springer, New York.
Epstein, J., McGaha, A. C. (1999). ATOD-TV: A Case Study on Developing Interactive
Multimedia. Journal of Technology in Human Services, 16, 17-31.
Epstein, J., Collins, K., Thomson, N. R. , Pancella, T., & Pauley, D. (2007). The doubles:
Evaluation of a substance abuse education curriculum for elementary school students.
Journal of Child and Adolescent Substance Abuse, 16, 1-22.
Epstein, J., Thomson, N. R., Collins, K. K., & Pancella, T. (2009). A longitudinal comparison
of two versions of an interactive multimedia substance abuse education program.
Journal of Child and Adolescent Substance Abuse, 18, 302-321.
Ferrini A, & Ferrini R. (2000). Health in the Later Years. 3rd edition. Boston, MA, McGraw
Hill.
Feinberg, L., Reinhard, S., & Choula, R. AARP, Public Policy Institute. (2011). Valuing the
invaluable: 2011 update the growing contributions and costs of family caregiving.
Fick D. M., Agostini J. V., Inouye S. K. (2002). Delirium superimposed on dementia: a
systematic review. Journal of American Medical Geriatric Society, 10, 1723-1732.
Field, T. S., Mazor, K. M., Briesacher, B., DeBellis, K. R., & Gurwitz, J. H. (2007). Adverse
drug events resulting from patient errors in older adults. Journal of American Geriatric
Society, 55, 271-276.
Fine, R. N., Becker, Y., De Geest, S., Eisen, H., Ettenger, R., Evans, R… & Dobbels, F. (2009).
Nonadherence consensus conference summary report. American Journal of
Transplantation, 9, 35-41.
Ford M. E., Kallen M., Richardson P., Matthiesen, E., Cox, V., Teng, E. J., Cook, K. F., &
Petersen, N. J. (2008). Effect of social support on informed consent in older adults with
Parkinson disease and their caregivers. Journal of Medical Ethics, 34, 41–47.

Medication Non-Adherence and Dementia

97

Forester B. P., & Oxman, T. E. (2003) Measures to assess the noncognitive symptoms of
dementia in the primary care setting. Primary Care Companion, 4, 158–163.

Fried L. P., & Walston, J. (2003). Frailty and failure to thrive. In: Hazzard WR, Blass ,IP,
Halter, IB, et al, eds. Principles of Geriatric Medicine and Gerontology. 5th ed. New
York, NY: McGraw- H ill; 1487-1502.
Gallagher-Thompson, D. & Steffen, A. (1994). Comparative effects of cognitive/behavioral
and brief psychodynamic psychotherapies for depressed family caregivers. Journal of
Consulting and Clinical Psychology, 62, 543-549.
Gallagher-Thompson, D., Haley, W., Guy, D., Rupert, M., Arguelles, T., Zeiss, M…Ory, M.
(2003). Tailoring Psychological Interventions for ethnically diverse dementia caregivers.
Clinical Psychology: Science and Practice, 10, 423-438.
Gallagher-Thompson, D., & Coon, D. W. (2007). Evidence-based psychological treatments for
distress in family caregivers of older adults. Psychology and Aging (March 2007).
George, N. R., & Steffen, A. M. (2015). Promoting medication adherence in older adults
through early diagnosis of neurocognitive disorders. Journal of Psychiatry: Primary
Care Companion to CNS Disorders.
Gifford, A., Bormann, J., Shively, M., Wright, B., Richman, D., Bozzette, S. (2000). Predictors
of self-reported adherence and plasma HIV concentrations in patients on multidrug
antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 23, 386395.
Graesel, M. (2002). When home care ends- Changes in the physical health of informal
caregivers caring for dementia patients: A longitudinal study. The American Geriatric
Society, 50, 843-849.
Gray, S. L., Mahoney, J. E., & Blough, D. K. (2001). Medication adherence in elderly patients
receiving home health services following hospital discharge. Annals of
Pharmacotherapy, 35, 539-535.
Grymonpre, R., Cheang, M., Fraser, M., Metge, C., Sitar, D. (2006). Validity of a prescription
claims database to estimate medication adherence in older persons. Medical Care, 44,
471-477.
Hayes, T. L., Hunt, J. M., Adami, A., & Kaye, J. A. (2006). An electronic pillbox for
continuous monitoring of medication adherence. Archives of Internal Medicine,
3. 6400-6403.

Medication Non-Adherence and Dementia

98

Heisler M., Langa K., Eby E. L., Fendrick, M., Kabeto, M. U., & Piette, J. D. (2004). The
health effects of restricting prescription medication use because of cost.” Medical Care,
7, 626-634.
Heneghan, C. J., Glasziou, P., Perera, R. (2007). Reminder packaging for improving adherence
to self-administered long-term medications. Cochrane Database of Systematic Reviews,
2, 50-63.
Higelman, M. M., Allen, R. S., DeCoster, J. & Burgio, L. D. (2007). Positive aspects of
caregiving as a moderator of treatment outcome over 12 months. Psychology and
Aging, 22, 361-371.
Hutchison, L. C., Jones, S. K., West, D. S., & Wei, J. Y. (2006). Assessment of medication
management by community-living elderly persons with two standardized assessment
tools: A cross-sectional study. The American Journal of Geriatric Pharmacotherapy,
4, 144-153.
Iihara N., Tsukamoto T., & Morita S. (2004). Beliefs of chronically ill Japanese patients that
lead to intentional non-adherence to medication, Journal of Clinical Pharmacotherapy,
29, 417-24
Inouye S. K. (2006). Delirium in older persons. New England Journal of Medicine,11, 1157
1165.
Insel, K. C., & Cole, L. (2005). Individualizing memory strategies to improve medication
adherence. Applied Nursing Research, 18, 199-204.
Institute of Medicine (IOM). (2007). Preventing medication errors. Philip Aspden, Julie
Wolcott, J. Lyle Bootman, Linda R. Cronenwett, eds. Washington, D.C.: National
Academies Press.
Ireland, S. E., Arthur, H. M., Gunn, E. A., & Oczkowski, W. (2010). Stroke prevention care
delivery: Predictors of risk factor management outcomes. International Journal of
Nursing Studies, 48, 156-164.
Jackson, D. (2011). A myriad of multiples: Many problematic factors contribute to
medication non-adherence in elders. Journal of the American Society on Aging, 35,
31-36.
Kamimura, T., Ishiwata, r., & Inoue, T. (2012). Medication reminder device for the elderly
patients with mild cognitive impairment. American journal of Alzheimer’s Disease
and other Dementias, 27, 238 – 242.

Medication Non-Adherence and Dementia

99

Kam-Mei, L. M., & Au, A. (2011). Correlates of informal caregiver distress in Parkinson’s
Disease: A meta-analysis. Clinical Gerontologist: The Journal of Aging and Mental
Health, 34, 117-131.
Katz, S., Ford, A., Moskowitz, R., Jackson, B., & Jaffe, M. (1963). Studies of illness in the
aged: The index of ADL, a standardized measure of biological and psychosocial
function. Journal of the American Medical Association, 185, 914-919.
Kazdin, A. (2003). Research design in clinical psychology: Fourth edition. Boston, MA:
Pearson Education Company.
King, D. K., Glasgow, R. E., Toobert, D. J., Stryker, L. A., Estabrooks, P. A., Osuna, D., &
Faber, A. J. (2010). Self-efficacy, problem solving, and social-environmental support
are associated with diabetes self- management behaviors. Diabetes Care, 33 751-753.
Kogos, S. (2004). Support groups and treatment adherence in a geriatric outpatient clinic.
Journal of Clinical Psychology in Medical Settings,11, 272-285.
Kripalani, S., Risser, J., Gatti, M., Jacobson, T. (2009). Development and evaluation of the
adherence to refills and medications scale (ARMS) among low-literacy patients with
chronic disease. Value in Health, 12, 118-123.
Kripalani, S., Yao, X., & Haynes, R .B. (2007). Interventions to enhance medication adherence
in chronic medical conditions: a systematic review. Archives of Internal Medicine, 167,
540–549.
Lawton, M. P. & Brody, E. (1969). Assessment of older people: Self-maintaining and
instrumental activities of daily living. The Gerontologist, 9, 179-186.
Levy, H. B. (2003). Self-administered medication risk questionnaire in an elderly population.
Annals of Pharmacotherapy,37, 982- 987.
Lewinsohn, P. (1974). A behavioral approach to depression. In Friedman, R., and Katz, M.
(eds.), The psychology of depression: Contemporary theory and research Wiley, New
York, p. 157-176.
Lewinsohn, P., Munoz, R., Youngren, M. & Zeiss, A.M. (1986). Control your depression, 2nd ed.
Englewood Cliffs, NJ: Prentice-Hall.
Lewis, L. M. (2011). Factors associated with medication adherence in hypertensive blacks: A
review of the literature. Journal of Cardiovascular Nursing, 3, 208-219.
Linnebur S. A., O’Connell M. B., Wessell A. M., McCord, A. D., Kennedy, D. H., DeMaagd,
G… ACCP Task Force. (2005). Pharmacy practice, research, education, and advocacy
for older adults. Pharmacotherapy, 25, 1396–1430.

Medication Non-Adherence and Dementia

100

Lorig K, Stewart A, Ritter P, González V, Laurent D, & Lynch J, Outcome Measures for Health
Education and other Health Care Interventions. Thousand Oaks CA: Sage Publications, 1996,
pp. 24,40.
Lovibond, S.H.; Lovibond, P.F. (1995). Manual for the Depression Anxiety Stress Scales (2nd ed.).
Sydney: Psychology Foundation (Available from The Psychology Foundation, Room 1005
Mathews Building, University of New South Wales, NSW 2052, Australia

MacLaughlin, E. J., Raehl, C. L., Treadway, A. K., Sterling, T. L., Zoller, D. P., & Bond, C. A.
(2005). Assessing medication adherence in the elderly: Which tools to use in clinical
practice. Drugs and Aging, 3, 231-255.
Maddigam, S. L., Farris, K. B., Keating, N., Wirnes, C. A., & Johnson, J. A. (2003). Predictors
of older adults’ capacity for medication management in a self-medication program: A
retrospective chart review. Journal of Aging and Health, 15, 332-352.
Martin, D., Kripalani, S., & DuRapau, V. J. (2012). Improving medication management among
at risk older adults. Journal of Gerontological Health, 6, 24-34.
Mcdonald-Miszcak, L., Maris, P., Fitzgibbon, T., & Ritchie, G. (2004). A pilot study examining
older adults’ beliefs related to medication adherence: The BERMA survey. Journal of
Aging and Health, 16, 591-614.
McPhail S, & Haines T. (2010). Response shift, recall bias and their effect on measuring change
in health-related quality of life amongst older hospital patients. Health and Quality of Life
Outcomes, 8, 63-65.
Mo, P., & Mak, W. (2009). Intentionality of medication non-adherence among individuals
living with HIV/ AIDS in Hong Kong.
Moon, H & Adams, K. B. (2012). The effectiveness of dyadic interventions for people with
dementia and their caregivers. Dementia, 12, 821- 839.
Mittleman, M., Roth, D., Coon, D. W. & Haley, W. E. (2004). Sustained benefit of supportive
interventions for depressive symptoms in caregivers of patients with Alzheimer’s disease.
American Journal of Psychiatry, 161, 850-856.
Morisky, D. E., Green L. W., & Levine D. M. (1986). Concurrent and predictive validity of a
self-reported measure of medication adherence Medical Care, 24, 67-74.
Morisky, D. E., Ang, A., Krousel-Wood, M., Ward, H. (2008). Predictive validity of a
medication adherence measure for hypertension control. Journal of Clinical
Hypertension, 10, 348-354.

Medication Non-Adherence and Dementia

101

Mishalia M., Omera, H., & Heymann A. D. (2010). The importance of measuring self-efficacy
in patients with diabetes. Family Practice, 28, 82-87.
Murray M. D., & Callahan C. M. (2003). Improving medication use for older adults: An
integrated research agenda. Annals of Internal Medicine, 5, 425-429.
Murray, M. D., Morrow, D. G., Weiner, M., Clark, D. O., Tu, W., Deer…& Weinberger, M.
(2004). A conceptual framework to study medication adherence in older adults. The
American Journal of Geriatric Pharmacotherapy, 2, 36-43.
Morrow D. G., Leier V. O., Andrassy J. M., Decker, E., Stine-Morrow, E. (1996). Medication
instruction design: younger and older adult schemas for taking medication. Human
Factors, 38, 556-73.
Narrow W. E. (2007). One-year prevalence of depressive disorders among adults 18 and over in
the U.S.: NIMH ECA prospective data.
National Alliance for Caregiving in Collaboration with AARP. (2009). Caregiving in the U.S.
http://www.caregiving.org/data/Caregiving_in_the_US_2009_full_report.pdf. Retrieved
January 25, 2013.
New England Healthcare Institute. (2009). Thinking outside the pillbox: A system-wide
approach to improving patient medication adherence for chronic disease.
www.nehi.net/publications/44/thinking_outside_the_pillbox_a_systemwide_approach_t
_improving_patient_medication_adherence_for_chronic_disease. Retrieved July 19,
2012.
Norman, P., Boer, H., & Seydel, E. R. (2005). Protection motivation theory. In M. Conner & P.
Norman (Eds.), Predicting Health Behavior Research and Practice with Social Cognition
Models, 2nd Ed (pp. 81-126). Maidenhead: Open University Press.
Nygaard R. W., Echt K. V., & Schuchard R. A. (2008). Models of reading performance in older
adults with normal age-related vision. Journal of Rehabilitation Research and
Development, 45, 901–910.
Office of Minority Health. (2011). HHS Action Plan to Reduce Racial and Ethnic Health
Disparities. A nation free of disparities in health and health care.
Office for National Statistics. (2005). Focus on Older People. Newport, UK: Office for
National Statistics.
Orwig, Denise, Rickles, N. M., & Martin, L. G. (2011). Methodological issues in
pharmacotherapy research in older adults. The American Journal of Geriatric
Pharmacotherapy, 9, 173-189.

Medication Non-Adherence and Dementia

102

Ory, M. G., Yee, J. L., Tennstedt, S. L., & Schulz, R. (2000). The extent and impact of dementia
care: Unique challenges experienced by family caregivers. In R. Schulz (Ed.),
Handbook on dementia caregiving: Evidence-based interventions for family caregivers
(pp. 1-32). New York, NY: Springer Publishing.
Papaioannou, A., Kennedy C. C., Dolovich L., Lau E., & Adachi J. D. (2007). Patient adherence
to osteoporosis medications: problems, consequences, and management strategies. Drugs
& Aging 24, 37–55.
Patel, R. P., & Taylor, S. D. (2002). Factors affecting medication adherence in hypertensive
patients. The Annals of Pharmacology, 35, 40-45
Peterson, A. M., Takiiya, L., & Finley, R. (2003). Meta-analysis of trials of interventions to
improve medication adherence. American Journal of Health Systems Pharmacy, 60, 657–
665.
Pew Research Center (2011). Who Doesn't Gather Health Information Online? Retrieved from
http://pewinternet.org/Commentary/2011/October/Who-Doesnt-Gather-HealthInformation-Online.aspx.
Pinquart, M. & Sorensen, S. (2003). Differences between caregivers and non-caregivers in
psychological health and physical health: A meta-analysis. Psychology and Aging,
18,250-267.
Ponpaipan, M. Srisuphan, W., Jitapunkul, S., Panuthai, S., Tonmukayakul, O., & While,
A. (2010). Multimedia computer-assisted instruction for carers on exercise for older
people: development and testing. Journal of Advanced Nursing, 308-316.
Radloff, L. (1977). The CES-D scale: A self-report depression scale for research in the general
population. Applied Psychological Measurement, 1, 385-401.
Reinhard, S. C., Given, B., Petlick, N. H., & Bemis, A. (2008). Chapter 14: Supporting family
caregivers and providing care. In Hughes, R. (Eds.), Patient Safety and Quality an
Evidence Based Handbook for Nurses (341-404). Rockville MD: Agency for Healthcare
Research and Quality.
Resnick, B., Wehren, L., & Orwig, D. (2003). Reliability and validity of the self-efficacy and
outcome expectations for osteoporosis medication adherence scales. Orthopedic
Nursing, 2, 139-147.
Roth, M. T., & Ivey, J. L. (2005). Self-reported medication use in community-residing older
adults: a Pilot study. The American Journal of Geriatric Pharmacotherapy, 3, 196-205.

Medication Non-Adherence and Dementia

103

Ruppar, T., Dobbels, S., & Geest, S. (2012). Medication beliefs and antihypertensive
adherence among older adults: A pilot study. Geriatric Nursing, 33, 89-95.
Salas, M., Veld, B. A., van der Linden, P.D., Hofman, A., Breteler, M., & Stricker, B. H.
(2001). Impaired cognitive function and compliance with antihypertensive drugs in
elderly: the Rotterdam Study. Clinical Pharmacotherapy, 70, 560-566.
Schlenk, E. A., Dunbar-Jacob, J., & Engberg, S. (2004). Medication non-adherence among
older adults: A review of strategies and interventions for improvement. Journal of
Gerontological Nursing, 30, 33–43.
Schmader, K. E., Hanlon, J. T., Pieper, C. F., Sloane, R., Ruby, C. M., & Twersky. (2004).
Effects of geriatric evaluation and management on adverse drug reactions and suboptimal
prescribing in the frail elderly. American Journal of Medicine, 116, 394–401.
Schroeder, K., Fahey, T., & Ebrahim, S. (2004). Interventions for improving adherence to
treatment in patients with high blood pressure in ambulatory settings. The Cochrane
database. The Cochrane Library, 2. 10.1002/14651858. CD004804.
Schulz R, O’Brien A. T., Bookwala J., & Fleissner, K. (1995). Psychiatric and physical
morbidity effects of dementia caregiving: Prevalence, correlates and causes.
Gerontologist, 35, 771–791.
Schulz R., & Martire L. M. (2004). Family caregiving of persons with dementia: prevalence,
health effects, and support strategies. American Journal of Geriatric Psychiatry, 12, 240249.
Schulz, R., Martire, L., & Klinger, J. (2005). Evidence-based caregiver interventions in geriatric
psychiatry. Psychiatry Clinics of North America, 28, 1007-1038.
Schüz, B , Marxa, C., Wurma, S., LWarnera, S., Ziegelmannb, J. P., Schwarzerb, R., & TeschRömera, C. (2011). Medication beliefs predict medication adherence in older adults
with multiple illnesses. Journal of Psychosomatic Research, 70, 179-187.
Sela-Katz, P., Rabinowitz, I., Shugaev, I., & Shigorina, G. (2010). Basic knowledge of the
medication regimen correlates with performance on cognitive function tests and diagnosis
of dementia in elderly patients referred to a geriatric assessment unit. Gerontology, 56,
491-495.
Selma T., & Rochon P. A. Pharmacotherapy. Geriatric Review Syllabus. 5th edition. American
Geriatric Society: Blackwell; 2002.
Siegel K., Karus D., & Schrimshaw E. W. (2000). Racial differences in attitudes toward
protease inhibitors among older HIV-infected men, AIDS Care, 12, 423-34.

Medication Non-Adherence and Dementia

104

Sikkes, S., De-Lange, E., Klerk, L., Pijnenburg, Scheltens, B., & Uitdehaag, B. (2011). A
systematic review of Instrumental Activities of Daily Living scales in dementia: room for
improvement. Journal of Neurology and Neurosurgical Psychiatry, 80, 7-12.
Smith, H., Hankins, M., Hodson, A., & George, C. (2009). Measuring the adherence to
medication of elderly patients with heart failure: Is there a gold standard? Elsevier, 10,
122-123.
Smith, G., Lunde, A. M., Hathaway, J. C., & Vickers, K. S. (2007). Telehealth home monitoring
of solitary persons with mild dementia. American Journal of Alzheimer’s Disease and
Other Dementias, 22, 20-26.
Solomon, D. S, Avorn, J., Katz, J. N., Finkelstein, J. S., Arnold, M., Polinski, J. M., &
Brookhart, A. (2005). Compliance with osteoporosis medications. Archives of Internal
Medicine, 165, 2414-2419.
Sorensen, S., Pinquart, M., & Duberstein, P. (2002). How effective are interventions with
caregivers? An updated meta-analysis. The Gerontologist, 42, 356-372.
Soumerai S. B., Pierre-Jacques M., Zhang F., Ross-Degnan, D., Adams, A. S., Gurwitz, J.,
Adler, G., & Safran. (2006). Cost related medication non-adherence among elderly and
disabled Medicare beneficiaries: A national survey 1 year before the Medicare drug
benefit. Archives Internal Medicine, 166, 1829–1835.
Spertus, J. A., Kettelkamp R., Vance C., Decker C., Jones P. G., Rumsfeld J. S… & Cohen D. J.
(2006). Prevalence, predictors, and outcomes of premature discontinuation of
thienopyridine therapy after drug-eluting stent placement. Circulation, 24, 2803–2809.
Steffen, A.M., McKibbin, C., Zeiss, A.M., Gallagher-Thompson, D., & Bandura, A. (2002). The
revised scale for caregiving self-efficacy: Reliability and validity studies. Journal of
Gerontology: Psychological Sciences, 57, 74–86.
Steffen, A. M., & Mangum, K. R. (2003). Distance-based interventions for depressed dementia
family carers. The Clinical Psychologist, 7, 1-10.
Sugita S., & Hasegawa, M. (2001) Health care providers-patients relationship. In: Yamazaki Y,
ed. The Sociology of Health and Medicine. Tokyo: University of Tokyo Press, 115–131.
Travis, S. S., Kao, H. S., & Acton, G. J. (2005). Helping family members manage medication
administration hassles. Journal of Psychosocial Nursing and Mental Health Services, 43,
13-15.
Thornton, M., & Travis, S.S. (2003). Analysis of the reliability of the modified caregiver strain
index. Journal of Gerontology: Social Sciences, 58B, S127-S132.

Medication Non-Adherence and Dementia

105

U.S. Census Bureau. (2004). U.S. Interim Projections by Age, Sex, Race, and Hispanic Origin.
Retrieved December 8, 2005 from, http://www.census.gov/ipc/www/usinterimproj/.
U.S. Census Bureau. 65+ in the United States: 2005. Washington, DC; 2005.
US Public Health Service. (2002). Older adults and mental health. In Mental Health: A Report of
the Surgeon General (on-line). http://www.surgeongeneral.gov/ Library/MentalHealth/
toc. html #chapter5.
US Dept of Health and Human Services. Chapter VI, Section H: Special classes of subjects. In:
Institutional Review Board Guidebook. 1993. http://www.hhs.gov/ohrp/
archive/irb/irb_chapter6.htm. Accessed July 18, 2012.
Van Eijken, M., Tsang, S., Wensing, M., de Smet, P. A., & Grol, R. P. (2003). Interventions to
improve medication compliance in older patients living in the community: a systematic
review of the literature. Drugs & Aging, 20, 229–240.
VanDyke, M. (in preparation). Validation of the Medication Hoarding Behaviors scale.
Vik, S. A., Maxwell, C. J., & Hogan, D. B. (2004). Measurement, correlates and health
outcomes of medication adherence among seniors. Annals of Pharmacotherapy, 38, 303312.
Vitaliano, P.P., Scanlan, J. M., Zhang, J., Savage, M. V., Hirsch, I. B., & Siegler, I. C. (2002). A
path model of chronic stress, the metabolic syndrome, and coronary heart disease.
Psychosomatic Medicine, 64, 418-435.
Vitaliano, P. P., Young, H. M., & Zhang, J. (2004). Is caregiving a risk factor for illness?
Current Directions in Psychological Science, 13, 13-16.
Weng, L. C., Dai, Y. D., Huang, H. L., & Chiang, Y. J. (2009). Self-efficacy, self-care
behaviors and quality of life of kidney transplant recipients. Journal of Advanced
Nursing, 66, 828-838.
Wierdsma, J. M., van Zuilen, A, & van der Bijl, J. (2011). Self-efficacy and long-term
medication use in patients with chronic kidney disease. Journal of Renal Care, 3, 158166.
Wilson I. R., Schoen C., Neuman P., Strollo M. K., Rogers, W. H., Chang, H., & Safran, D.
(2007). Physician-Patient communication about prescription medication nonadherence: A
50-state study of America’s seniors. Society of General Internal Medicine, 1, 6-12.
Zarit, S. H., & Zarit, J. M. (2007). Mental disorders in older adults. Chapter 13: Family
Caregiving. New York, NY: Guilford Press.

Medication Non-Adherence and Dementia

106

Appendix A.
Contact Timeline for Intervention Groups
Narrative Group Contact Timeline
 Participant completes screening
assessment. Assessment program
emails project coordinator that
someone has qualified for project.
 Project Coordinator Sends “Email
1/ Introductory assessment email ”
 Record date email was sent in the
participant tracking form.
 The 4th pre-assessment survey
generates an automatic email when
completed.
 Send email 2 “Introduction to
intervention with login ID and
password: Experimental Condition”
 In sandwichgenerationdiner.com
assign login ID, password and User
Level one for narrative condition.
 One week later, send “email 3, after
one week”
 Increase Participant access level to
week 2 of narrative condition.
 One week later send “email 4 after
2 weeks”
 Increase participant access level to
week 3 of narrative condition.
 One week later send “email 5 after
3 weeks”
 Also Send the “5 wishes email”
 Increase participant access to week
4 (final level) of narrative
condition.
 One week later, a total of 4 weeks
after the login ID email, send the
“post-test assessment” email
 The 4th survey in this group
generates an automatic email when
completed.

Didactic Group Contact Timeline
Participant completes screening
assessment. Assessment program
emails project coordinator that
someone has qualified for project.
 Project Coordinator Sends “Email 1/
Introductory assessment email ”
 Record date email was sent in the
participant tracking form.
 The 4th pre-assessment survey
generates an automatic email when
completed.
 Send email 2 “Introduction to
intervention with login ID and
password: Control condition”
 In sandwichgenerationdiner.com
assign login ID, password and User
Level one for didactic condition.
 One week later, send “email 3, after
one week”
 Increase Participant access level to
week 2 of didactic condition.
 One week later send “email 4 after 2
weeks”
 Increase participant access level to
week 3 of didactic condition.
 One week later send “email 5 after 3
weeks”
 Also Send the “5 wishes email”
 Increase participant access level to
week 4 (final level) of didactic
condition
 One week later, a total of 4 weeks
after the login ID email, send the
“post-test assessment” email
 The 4th survey in this group
generates an automatic email when
completed.
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Appendix B

Treatment Condition Content Areas
Week

Narrative condition

Didactic Condition

1

Medication Management
 Organizing Meds (PDF)
 Introduction (Dyad Video)
 Organizing Meds (Dyad Video )
Talking Together
 Basic Communication Tips (PDF)
 Introduction (Dyad Video)
 Basic Communication (Dyad Video)
Signs of Confusion
 Causes of Confusion (PDF)
 Causes of Confusion (Expert Video)
 10 Warning Signs (PDF)
 Introduction (Dyad video)
 Causes of Confusion (Dyad Video)
Healthcare Visits
 Getting Ready for a Healthcare Visit
(PDF)
 Introduction (Dyad Video)
 Getting Ready (Dyad Video)

Medication Management
 Organizing Meds (PDF)
Talking Together
 Basic Communication Tips
(PDF)
Signs of Confusion
 Causes of Confusion (PDF)
 Causes of Confusion
(Expert Video)
 10 Warning Signs (PDF)
Healthcare Visits
 Getting Ready for a
Healthcare Visit (PDF)

2

Medication Management
 Ask Your Pharmacist (PDF)
 Ask Your Pharmacist (Expert Video)
 Ask Your Pharmacist (Dyad Video )
Talking Together
 Handling Minor Disagreements (PDF)
 Minor Disagreements (Dyad Video)
Signs of Confusion
 Why get a Diagnosis (PDF)
 Getting a Diagnosis Step 1 (Dyad Video)
Healthcare Visits
 Learning about Meds (PDF)
 Learning about Meds (Dyad Video)

Medication Management
 Ask Your Pharmacist
(PDF)
 Ask Your Pharmacist
(Expert Video)
Talking Together
 Handling Minor
Disagreements (PDF)
Signs of Confusion
 Why get a Diagnosis
(PDF)
Healthcare Visits
 Learning about Meds
(PDF)

3

Medication Management
 Over the Counter Meds (PDF)
 Taking Time for More Questions (PDF)

Medication Management
 Over the Counter Meds
(PDF)
 Taking Time for More
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4

Taking Time for More Questions (Dyad
Video )
Talking Together
 Handling Major Disagreements (PDF)
 Major Disagreements (Dyad Video)
Signs of Confusion
 Getting a Diagnosis (PDF)
 AD8 (PDF)
 Getting a Diagnosis Step 2 (Dyad Video)
Healthcare Visits
 Release Forms (PDF)
 Side Effects (PDF)
 Side Effects (Expert Video)
 Release Forms and Side Effects (Dyad
Video)
Medication Management
 Fine Tuning Questions For Your
Pharmacist (PDF)
 Fine Tuning (Dyad Video)
Talking Together
 Planning for the Future (Expert Video)
 Housing Plans (PDF)
 Transportation Plans (PDF)
 Healthcare Plans (PDF)
 Long Term Plans (PDF)
 Financial Plans (PDF)
 Values and Plans (Dyad Video)
Signs of Confusion
 Following a Dementia Diagnosis (PDF)
 Following a Dementia Diagnosis (Dyad
Video)
Healthcare Visits
 Affording Meds (PDF)
 Affording Meds (Dyad Video)

108
Questions (PDF)
Talking Together
 Handling Major
Disagreements (PDF)
Signs of Confusion
 Getting a Diagnosis (PDF)
 AD8 (PDF)
Healthcare Visits
 Release Forms (PDF)
 Side Effects (PDF)
 Side Effects (Expert
Video)

Medication Management
 Fine Tuning Questions For
Your Pharmacist (PDF)
Talking Together
 Planning for the Future
(Expert Video)
 Housing Plans (PDF)
 Transportation Plans (PDF)
 Healthcare Plans (PDF)
 Long Term Plans (PDF)
 Financial Plans (PDF)
Signs of Confusion
 Following a Dementia
Diagnosis (PDF)
Healthcare Visits
 Affording Meds (PDF)
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Appendix C

Timeline for Project
Study Start up – July 2013  Dec 2013
Recruitment- December 2013  October 2014
Intervention- December 2013  October 2014
Analysis and Writing- October 2014  April 2015

Study Start up
July 2013December
2013

Recruitment
and
Intervention
Dec 2013- Oct
2014

Analysis and
Writing
Oct 2014- April
2014
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Appendix D

Student Duties

Startup
• Time investment: 20- 40 hours per week
• Creation of Intervention
• Create all Didactic Handouts
• Provide outlines for script writers detailing narrative vignette content
areas based in self-efficacy theory
• Revise script
• Consult with healthcare professionals about didactic content
• Consult with web designers about layout of intervention website and
issues of online measurement and assessment/ screener set-up
• Measure Selection
• Create and Submit IRB for Intervention
• Create all online assessments and screens through Qualtrics

Recruitment
• Time investment: 20-40 hours per week
• Perform all recruitment duties and project management

Intervention
• Time investment: 20-40 hours per week
• Monitor each individual's intervention progress
• Send reminder emails for individual participation
• Direct participant financial compensation
• Provide Tech Support

Analysis and Writing
• Perfrom all duties related to dissertation analysis and writing

